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ABSTRACT
Manganese is an essential trace mineral that, at high 
doses, damages the dopamine neurotransmitter system.
Evidence suggests that children may be particularly prone
to manganese neurotoxicity and may have an amplified risk
of neuronal damage. Infant formulas contain substantially
more manganese than the recommended daily allowance, so
this sub-population of infants may be at particular risk
for developing long-term behavioral deficits and neuronal
alterations. The purpose of this thesis, therefore, was to
examine the effects of low to moderate doses of manganese
(0, 250, or 750 pg per day from PD 1-21) on a comprehensive
battery of behaviors during the neonatal period,
preweanling period, and in adulthood. Additionally, this
thesis evaluated manganese-induced changes in dopamine
transporter binding sites. Manganese exposure did not
affect the appearance of developmental landmarks, nor did
it alter neonatal motor activity or olfactory orientation.
Manganese did impair neonatal motor coordination and
depressed body weight gain on PD 13-21. Manganese exposure
did not affect basal motor activity, balance, or
coordination. When tested at PD 90, however, manganese-
exposed rats exhibited both reduced responding on a
iii
differential reinforcement of low rates of response (DRL)
task and a reduction in cocaine-induced motor activity.
Moreover, early manganese exposure caused a persistent
reduction of striatal dopamine transporters. Manganese did
not alter the rewarding properties of cocaine, as measured
by the acquisition, extinction, and reinstatement of
jconditioned place preference. When considered together, the
most parsimonious conclusion is that early manganese
exposure causes neurotoxicity, which is evidenced by short-
and long-term changes in behavior and reductions in
striatal dopamine transporters.
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CHAPTER ONE
MANGANESE AND HUMAN EXPOSURE
Introduction
Manganese is a complex trace mineral that has opposing
roles as an essential nutrient and a potential
neurotoxicant. The roles oppose because although manganese
is potentially harmful to the central nervous system, it is
an important trace mineral required to maintain enzyme
levels and cellular transmission throughout the body
(Aschner, Vrana, & Zheng, 1999). Most people get an
appropriate amount of manganese through dietary intake of
natural foods such as whole grains, legumes, avocados,
blueberries, and green leafy vegetables (Aschner et al.,
1999). Failure to maintain basal levels of manganese can
cause seizure activity and skeletal abnormalities
(Critchfield, Carl, & Keen, 1993; Zidenberg-Cherr, Keen,
Lonnerdal, & Hurley, 1983). However, since sufficient
quantities of manganese are typically obtained through
diet, dietary deficiencies are secondary to the threat of
overexposure (Aschner et al., 1999).
The toxic effects of manganese were first identified
in 1837 by a doctor who treated five patients that inhaled
1
excessive amounts of manganese in a pyrolusite mill (Cawte,
1985). Since then manganese poisoning has been reported
world-wide in factory alloy workers and miners (Beuter,
Edwards, deGeoffrou, Mergler, & Hudnell, 1999; Cawte, 1985;
Lucchini, Bergamaschi, Smargiassi, Festa & Apostoli, 1997;
Mergler et al., 1994), as well as in individuals
accidentally exposed to manganese in drinking water (He,
Liu, & Zhang, 1994; Woolf, Wright, Amarasiriwardena, &
Bellinger, 2002).
Behavioral and neurological manifestations of
manganese poisoning differ depending upon the length of
exposure. Early in the illness, behavioral symptoms are
similar to schizophrenia, including compulsiveness, violent
behavior, emotional instability, and hallucinations
(Aschner, 2000; Beuter et al., 1999; Mergler, 1999; Mergler
et al., 1994). These initial symptoms are later replaced by
extrapyramidal motor system impairments that result in
bradykinesia and dystonia (Aschner, 2000). Additionally,
manganese-intoxicated individuals gradually lose speech
capabilities: speech becomes slurred, slow and irregular,
while voices become monotone and low (Aschner, 2000).
Although the final stages of chronic manganese poisoning
closely resemble Parkinson's disease (i.e., manganese
2
poisoning and Parkinson's disease are both characterized by 
bradykinesia and widespread muscular rigidity), the
differences between the two disorders are distinct.
Specifically, manganese poisoning is characterized by less
intense resting tremor, more frequent dystonia, the
propensity to fall backwards, and inconsistent responding
to levodopa (Caine, Chu, Huang, Lu, & Olanow, 1994).
Importantly, these clinical symptoms progressively worsen
even after exposure has stopped and tissue mineral
concentrations have returned to normal levels (Hochberg et
al., 1996; Huang, Chu, Lu, Chen, & Caine, 1998; Huang, Lu,
Chu, Hochberg, Lilienfeld, Olanow, & Caine, 1993).
Manganese and Parenteral Nutrition 
Supplementation
There are no reports that normal dietary intake causes
manganese poisoning; however, children and adults receiving
parenteral nutrition supplementation occasionally suffer
from manganese intoxication (Dickerson, 2001; Fell et al.,
1996; Komaki, Maisawa, Sugai, Kobayashi, & Hashimoto, 1999;
Nagatomo et al., 1999). In separate case studies, two adult
patients were admitted into hospital care following several
months of total parenteral nutrition that increased
manganese levels to. 20 pmol daily (Nagatomo et al., 1999).
3
Both patients exhibited classic symptoms of manganese
poisoning that included psychiatric and Parkinsonian 
symptoms (Nagatomo et al., 1999).
Similar to adults, children exposed to high levels of
manganese during parenteral nutrition supplementation have
both higher levels of whole blood manganese and an excess
accumulation of manganese in certain brain regions (e.g.,
the basal ganglia) (Fell et al., 1996; Komaki et al.,
1999). Children with the highest whole blood manganese
concentrations demonstrated dystonic limb movements,
abnormal posturing, seizure, tremor, and abnormal MRI (Fell
et al., 1996; Komaki et al., 1999). For children and
adults, psychiatric and behavioral dysfunctions subsided
after manganese supplementation was discontinued (Komaki et
al., 1999).
Manganese and Environmentally 
Exposed Children
Very little is known about the consequences of
manganese exposure during infancy or childhood; however, it
is generally believed that children may be more susceptible
to manganese neurotoxicty than adults (Cawte, 1985;
Kostial, Kello, Jugo, Rabar, & Maljkovic, 1978; Mergler,
1999; Weiss, 1999). In China, children exposed to elevated
4
manganese in drinking water performed worse than controls
on short-term memory tasks, manual dexterity tasks, and
visuo-perceptual tasks (He et al., 1994). A case study in
the United States provided similar results, because a boy
inadvertently exposed to manganese through drinking water
had difficulty performing memory tasks and coordinating
rapid alternating motor movements (Woolf et al., 2002).
Manganese and Infant Formula
It has been established that exposure to high doses of
manganese induces toxicity. Conseguently, there is
increasing concern that chronic exposure to lower amounts
of manganese may also have toxic effects (Lucchini et al.,
1997; Mergler, 1999). Children could be at particular risk,
because a child's diet in the United States typically
exceeds the daily requirement for maintaining basal
manganese levels (Hunt & Meacham, 2001; Milner, 1990). For
example, the recommended daily manganese requirement for
infants ranges from 0.3 mg to 0.6 mg (Milner, 1990). In the
United States, the average dietary intake of manganese for
infants is 1.0 mg/kg per day, with 49% of the daily intake
being provided through infant foods (Hunt & Meacham, 2001).
Importantly, commercially available infant formulas contain
5
substantially more manganese than human milk (Lonnerdal,
1994). Specifically, human milk contains approximately 3-8
pg/1 manganese, while cow milk-based formulas contain 50-
100 pg/1 manganese, and soy-based products contain as much 
as 200-300 pg/1 manganese (Lonnerdal, 1994). The high
manganese levels in soy-based formulas are of particular
concern, because these types of formulas are commonly
recommended for infants with protein allergies, lactose
intolerance, or general gastrointestinal discomfort
(Lonnerdal, 1994).
Manganese and Attention Deficit/
Hyperactivity Disorder
Manganese levels in infant formulas are of particular
interest because these levels may be sufficient to cause
lasting learning disabilities and behavioral dysfunctions
associated with Attention Deficit/Hyperactivity Disorder
(ADHD) (Cawte, 1985; Lonnerdal, 1994; Weiss, 1999). Several
lines of evidence support manganese involvement in ADHD.
Before discussing this evidence in detail, however, the
next section will provide an overview of ADHD
classifications, behavioral manifestations, and
neuroimaging studies.
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Attention Deficit/Hyperactivity Disorder
The prevalence of ADHD is reported to be between 3%-
7% of school age children (American Psychiatric
Association, 1994), making this disorder one of the most
commonly diagnosed neurological disorders among children
and adolescents in the United States (Solanto, 1998) . ADHD
is characterized by persistent inattention, hyperactivity,
and/or impulsivity. These characteristics are exaggerated
and disabling in individuals with the disorder and are
inconsistent with typical behavior within the individual's
developmental period (American Psychiatric Association,
1994) .
The Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV divides behavioral symptoms into two
basic categories: inattention and hyperactivity/impulsivity
(American Psychiatric Association, 1994). These two
categories are further classified into three different
diagnostic subtypes: ADHD Predominantly Inattentive Type,
ADHD Predominantly Hyperactive-Impulsive Type, or ADHD
Combined Type. Additionally, ADHD can co-occur with other
psychiatric conditions including oppositional defiance
disorder, conduct disorder, mood disorders and
7
Tourette's/tic disorders (Goldman, Genel, Bezman, &
Slanetz, 1998).
Attention Deficit/Hyperactivity Disorder and
Behavioral Dysfunction
In laboratory assessments, ADHD patients display a
wide variety of behavioral dysfunctions. For example, ADHD
children exhibit impairments on short-term memory tasks
(Paule et al., 2000), complex visual memory tasks (Berman,
Douglas, & Bar, 1999), and on nonverbal learning and memory
tasks (O'Toole, Abramowitz, Morris, & Dulcan, 1997).
Inattentiveness and impulsivity interfere with the ability
of ADHD children and adults to exhibit sustained attention
(Oades, 2000; Solanto, Wender, & Bartell, 1997; Swaab-
Barneveld et al., 2000; van der Meere, Shalev, Borger, &
Gross-Tsur, 1995). Tasks that require participants to
withhold a previously conditioned or reinforced motor
response are difficult for children, adolescents, and
adults with ADHD (Dinn, Robbins, & Harris, 2001; Nigg,
1999; Schachar, Moto, Logan, Tannock, & Klim, 2000).
Additionally, ADHD children show an inability to perform
tasks that require temporal processing in order to
correctly execute a response (Barkley, Koplowitz, Anderson,
& McMurray, 1997; Gordon, 1979; McClure & Gordon, 1984).
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Attention Deficit/Hyperactivity Disorder and
Neuroimaging
Neuroimaging techniques consistently reveal
differences in the frontal cortex, caudate nucleus, and
globus pallidus of ADHD and nonADHD patients. Specifically,
ADHD boys, when compared to controls, have 5% less total
brain volume (Castellanos et al., 1994), 4.7% less total
cerebral volume (Castellanos et al., 1996), and less
frontal cortex volume (Filipek et al., 1997). In normal
children, the caudate nucleus exhibits a size asymmetry;
however, ADHD children do not show typical right > left
asymmetry (Castellanos et al., 1994, 1996; Mataro, Garcia-
Sanchez, Junque, Estevez-Gonzalez, & Pujol, 1997). The
degree to which caudate asymmetry is abnormal is correlated
with the inattentiveness exhibited by ADHD individuals
(Schrimsher, Billingsley, Jackson, & Moore, 2002) .
Additionally, ADHD is characterized by atypical caudate
maturation. Specifically, caudate volume normally decreases
substantially across maturation; however, the caudate
volume of children with ADHD does not show the normal
decline (Castellanos et al., 1994). Conversely, the globus
pallidus, but not the'putamen, is smaller in people
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diagnosed with ADHD (Aylward, 1996; Castellanos et al.,
1996; Giedd, Blumenthal, Molloy, & Castellanos, 2001).
These volumetric differences are consistent with
positron emission tomography (PET) studies and single
photon emission computerized tomography (SPECT) studies
that demonstrate decreased metabolism in the frontal lobes
and striatum (i.e., caudate-putamen) of ADHD patients
(Ernst, Zametkin, Matochik, Jons, & Cohen, 1998; Lou,
Henrikson, Bruhn, Berner, & Nielsen, 1989; Zametkin et al.,
1990). Additionally, functional magnetic resonance imaging
(fMRI) studies have shown decreased activation of the
frontal lobes and striatum during performance of cognitive
tasks that require inhibition of a previously reinforced
response (Durston et al., 2003; Rubia et al., 1999, 2000;
Teicher et al., 2000; Vaidya & Gabrieli, 1999).
Taken together, these various neuroimaging techniques
consistently demonstrate that corticostriatal circuitry is
dysfunctional in ADHD (Casey et al., 1997; Johansen, Aase,
Meyer, & Sagvolden, 2002; Solanto, Wender, & Bartell,
1997). In addition, dysfunction of the nigrostriatal
dopamine system has been implicated in motor abnormalities
associated with ADHD, while dysfunction of the
mesolimbocortical system has been implicated in altered
10
reward function (Johansen et al., 2002; Sagvolden et al.,
1998).
Relationship Between Manganese Toxicity and
Attention Deficit/Hyperactivity Disorder
As mentioned previously, there is evidence suggesting
a causal relationship between manganese toxicity and ADHD.
Manganese levels in hair samples provide the first line of
evidence. Trace minerals, including manganese, found in
hair samples accumulate at a differential rate depending on
age and sex of the child (Collipp, Chen, & Maitinsky, 1983;
Sakai, Wariishi, & Nishiyama, 2000). Therefore, it is not
surprising that children directly exposed to manganese show
increased concentrations of the mineral in hair samples (He
et al., 1994; Fell et al., 1996; Komaki et al., 1999; Woolf
et al., 2002). Interestingly, learning disabled children
also have elevated levels of manganese in their hair
samples, even though they have not been previously exposed
to excessive levels of the mineral (Collipp, Chen, &
Maitinsky, 1983; Pihl & Parkes, 1977). Consequently, these
data suggest that absorption and retention of environmental
metals may be directly related to the development of
learning disabilities as well as disruptive and hyperactive
behaviors, and emotional disturbances (Marlowe & Bliss,
11
1994; Marlowe, Schneider, & Bliss, 1992). Not surprisingly,
manganese concentrations in hair are higher in formula-fed
infants than in breast-fed infants (Collipp, Chen, &
Maitinsky, 1983).
Neurobehavioral tasks also suggest that a causal
relationship may exist between manganese toxicity and ADHD
(Barkley, Koplowitz, Anderson, & McMurray, 1997; Durston et
al., 2003; Rubia et al., 1999, 2000; Teicher et al., 2000;
Vaidya & Gabrieli, 1999). Although manganese neurotoxicity
has not been directly associated with function of the
frontal cortex (Calabrassi et al., 2001; Kontur & Fletcher,
1985), manganese impairs performance on neurobehavioral
tasks mediated by corticostriatal circuitry. For example,
manganese-exposed children show memory impairment, poor
manual dexterity skills, and poor motor coordination, which
are consistent with behavioral alterations observed in ADHD
children (i.e., memory, motor, attention, and response
inhibition difficulty) (He et al., 1994; Woolf et al.,
2002). Combined, these results suggest that both manganese
neurotoxicity and ADHD may involve alterations of
corticostriatal functioning, which is indicated by
disinhibition of performance on neurobehavioral tasks
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(Barkley, 1997, 2003; Calabrassi et al., 2001; Casey et
al., 1997).
Another line of evidence, provided by neuroimaging
studies, suggests that the same neural substrates are
involved in both manganese toxicity and ADHD. More
precisely, manganese toxicity and ADHD involve dopamine 
system impairment of the nigrostriatal and mesolimbic 
pathways. Manganese accumulates in the same basal ganglia
nuclei (i.e., striatum and globus pallidus) that are
consistently found by neuroimaging studies to function
abnormally in ADHD (Durston et al., 2003; Erickson et al.,
2002; Lou et al., 1989; Teicher et al., 2000; Vaidya &
Gabrieli, 1999). Abnormal functioning of the nigrostriatal
dopamine pathway is responsible for the motoric dysfunction
observed in both manganese intoxication and ADHD (Aschner,
2000; Aylward, 1996; Castellanos et al., 1996; Erickson et
al., 2002; Giedd, Blumenthal, Molloy, & Castellanos, 2001;
Johansen et al., 2002). Motoric dysfunction is most
typically expressed as impaired timing assessments, poor
motor control, hyperactivity, and impulsivity (Johansen et
al., 2002; Kadesjjo & Gillberg, 1999; Sagvolden et al.,
1998).
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Another neural substrate involved in both manganese
neurotoxicity and ADHD is the globus pallidus. Neuroimaging
studies suggest that the globus pallidus functions
abnormally in ADHD, perhaps preventing normal responding to
reinforcing or rewarding events (Barkley, 1997, 2003;
Douglass & Parry, 1994; Johansen et al., 2002; Sagvolden et
al., 1998). Manganese accumulation in the globus pallidus
may interrupt reward processes, because stimulation of
dopamine terminals in this brain region increases
responding for drug and food reward (Fletcher, Korth,
Sabijan, & DeSousa, 1998; Olive & Maidment, 1998; Ono,
Nishijo, & Nishino, 2000). Taken together, the brain areas
affected by manganese accumulation are the same areas
implicated in ADHD; therefore, it is reasonable to suggest
that manganese accumulation in the basal ganglia may cause
motoric dysfunction and reward deficiencies consistent with
symptoms observed in ADHD.
Summary
This chapter provides evidence that manganese is
neurotoxic to adults and children. Humans are primarily
exposed to manganese via environmental contamination
(Beuter et al., 1999; Cawte, 1985; He et al., 1994; Mergler
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et al., 1994; Woolf et al., 2002) or orally through
parenteral nutrition (Dickerson, 2001; Fell et al., 1996; 
Komaki et al., 1999; Nagatomo et al., 1999). At high doses,
manganese causes motoric and cognitive dysfunction
(Aschner, 2000; Beuter et al., 1999; Cawte, 1985; Mergler
et al., 1994); however, it is unclear if low doses cause
similar behavioral and cognitive symptoms. There is
increasing evidence that children may be particularly prone
to manganese neurotoxicity, because infant formulas contain
about 50% more manganese than the recommended daily
allowance (Hunt & Meacham, 2001). Children fed these
formulas may be at risk for lasting brain changes that
result in long-term behavioral dysfunction (Cawte, 1985;
Lonnerdal, 1994; Mergler, 1999; Weiss, 1999). Specifically,
a causal relationship may exist between manganese exposure
and ADHD (Cawte, 1985; Lonnerdal, 1994; Weiss, 1999).
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CHAPTER TWO
BASAL GANGLIA CIRCUITRY
Introduction
Based on data presented in Chapter 1, it is apparent
that manganese has toxic effects in both children and
adults. These neurotoxic effects are manifested as changes
in cognition, personality, and gross motor movement. The
accumulated evidence indicates that these changes are a
result of manganese-induced alterations of central nervous
system functioning. Manganese also affects a variety of
neurotransmitter systems, with most of the research
implicating dopamine, glutamate, and y-aminobutyric acid
(GABA). Manganese-induced changes in neurotransmission are
predominantly found in the basal ganglia; therefore, the
purpose of Chapter 2 will be to provide background
information about neurotransmitter system functioning
within the basal ganglia.
Basal Ganglia Circuitry: Structure
The basal ganglia consists of four primary nuclei: the
striatum (caudate nucleus and putamen), the globus pallidus
(internal and external segments), the substantia nigra
(pars reticulata and pars compacta), and the subthalamic
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nucleus (Albin, Young, & Penny, 1989; Alexander & Crutcher,
1990; De Long, 2000) . These nuclei are involved in
mediating voluntary motor movement, oculomotor movement,
emotion, executive functioning, and motivation (Alexander,
Crutcher, & DeLong, 1990; Hoover & Strick, 1993, 1999).
Pathways between the cortex, basal ganglia, thalamus, and
brain stem make up the basal ganglia-thalamocortical
circuits (see Figure 1)(Alexander et al., 1990).
Specifically, the basal ganglia receives input from the
cortex and sends information back to the cortex via
connections with the thalamus (Alexander et al., 1990). The
primary input nucleus of the basal ganglia is the striatum
(Albin et al., 1989; De Long, 2000), although the
subthalamic nucleus also receives excitatory glutamatergic
input from the cortex (Afsharpour, 1985; Alexander &
Crutcher, 1990; Carlson & Carlson, 1990; De Long, 2000;
Greenamyre, 2001; Young, Bromberg, & Penny, 1981).
The primary output structures of the basal ganglia are
the globus pallidus internal segment and substantia nigra
pars reticulata (SNr), which are functionally similar
nuclei (Albin et al., 1989; De Long, 2000). Although the
17
Cortex
Figure 1. Schematic representation of basal ganglia- 
thalamocortical circuitry.
Abbreviations: GPe, globus pallidus external segment; GPi, 
globus pallidus internal segment; SNr, substantia nigra 
pars compacta; SNr, substantia nigra pars reticulate.
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thalamus is not considered part of the basal ganglia, it 
has an important role in basal ganglia-thalamocortical 
circuitry. Specifically, the thalamus receives inhibitory 
GABAergic input from the SNr and GPi and, in turn, sends 
excitatory glutamatergic output to the cortex (Albin et
al., 1989; Alexander & Crutcher, 1990; Alexander et al.,
1990; Carlson & Carlson, 1990; De Long, 2000; Greenamyre,
2001).
The cortex provides glutamatergic input to the
striatum which, in turn, inhibits two parallel pathways:
the direct pathway and the indirect pathway (Albin et al.,
1989; Alexander & Crutcher, 1990; Alexander et al., 1990;
De Long, 2000). The direct pathway consists of striatal
cells projecting to the SNr and Globus pallidus internal
segment (Albin et al., 1989; Alexander & Crutcher, 1990;
Alexander et al., 1990; De Long, 2000). The indirect
pathway begins with striatal efferents projecting from the
striatum to the GPe, then from the GPe to the subthalamic
nucleus, and finally from the subthalamic nucleus to the
SNr and globus pallidus internal segment (Albin et al.,
1989; Alexander & Crutcher, 1990; Alexander et al., 1990;
De Long, 2000; Greenamyre, 2001).
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In terms of neurotransmitters, 90% of striatal neurons
are GABAergic (Alexander et al., 1990; De Long, 2000;
O'Conner, 1998). The remaining 10% of striatal neurons,
consisting of substance P, dynorphin, enkephalin,
neurotensin, and acetylcholine interneurons, are
responsible for regulating tonic control of the striatum
(Alexander et al., 1990; De Long, 2000; O'Conner, 1998).
The neurons of the direct pathway co-release GABA,
dynorphin, and substance P in the SNr and Globus pallidus
internal segment (Albin et al., 1989; De Long, 2000),
whereas neurons of the indirect pathway co-release GABA,
enkephalin, and neurotensin in the globus pallidus external
segment (GPe) (Albin et al., 1989; De Long, 2000) . In
addition, GABA neurons project from the GPe to the
subthalamic nucleus (Albin et al., 1989; De Long, 2000).
Glutamate axons project from the subthalamic nucleus to the
SNr and Globus pallidus internal segment, which is the only
excitatory connection involving basal ganglia circuitry
(Afsharpour, 1985; Alexander & Crutcher, 1990; Carlson &
Carlson, 1990; De Long, 2000; Greenamyre, 2001; Young,
Bromberg, & Penny, 1981).
Dopaminergic cell bodies in the SNc project to the
striatum, where they synapse on cells of the direct and
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indirect pathways (Albin et al., 1989; Alexander &
Crutcher, 1990; Alexander et al., 1990; De Long, 2000).
Specifically, excitatory Di-like dopamine receptors are
located on neurons composing the direct pathway; whereas,
inhibitory D2~like dopamine receptors are located on neurons
of the indirect pathway (De Long, 2000; Gerfen, 1992;
Gerfen, Engber, Mahan, Susel, Chase, Monsma, & Sibley,
19 90; O'Conner, 1998)".
Basal Ganglia Circuitry: Function
As just mentioned, basal ganglia-thalamocortical
circuits are involved in a variety of behavioral and motor
functions via parallel pathways that begin and end in
specific areas of the cortex and engage different areas of
the basal ganglia and thalamus (Alexander et al., 1990;
Alexander & Crutcher, 1990; De Long, 2000; Hoover & Strick,
1993, 1999). Activation of the direct pathway disinhibits
thalamocortical transmission. More specifically, the
inhibitory drive of striatal GABAergic projections to the
SNr and Globus pallidus internal segment, in turn, inhibits
GABA transmission to the thalamus (Alexander et al., 1990;
Alexander & Crutcher, 1990). In contrast, activation of the
indirect pathway ultimately results in increased inhibition
21
of the thalamus via glutamatergic projections from the
subthalamic nucleus. In this case, increased activation of
striatal GABAergic projections to the GPe suppresses
neuronal firing, which decreases inhibitory control over
the subthalamic nucleus (Alexander et al., 1990; Alexander
& Crutcher, 1990). Disinhibition of the subthalamic nucleus
increases excitatory glutamatergic transmission to the SNr
and Globus pallidus internal segment, which ultimately
increases the inhibitory drive to the thalamus (Alexander
et al., 1990; Alexander & Crutcher, 1990). To summarize,
activation of the direct pathway disinhibits the thalamus
increasing thalamocortical transmission, while activation
of the indirect pathway causes increased inhibition of
thalamocortical neurons (Alexander & Crutcher, 1990;
Alexander et al., 1990; De Long, 2000).
Dopamine modulates this system. In the striatum, Di-
like and D2-like receptors are located on different sets of
neurons and modulate both the direct and indirect pathway.
Specifically, stimulation of striatal Di-like receptors
increases the firing rate of the striatonigral GABAergic
pathway (i.e., the direct pathway), which results in
disinhibition of the thalamus (Gerfen, 1992; Gerfen et al.,
1990; ■O'Conner, 1998). Stimulation of striatal D2-like
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receptors reduces the firing rate of the striatopallidal
GABA pathway (i.e., the indirect pathway), which decreases
inhibition of the thalamus (Gerfen, 1992; Gerfen et al.,
1990; O'Conner, 1998). Although striatal Dx-like and D2-like
receptors modulate different pathways, ultimately both
receptor types facilitate motor movement by reducing
inhibition of thalamocortical neurons (De Long, 2000;
Gerfen, 1992; Gerfen et al., 1990; O'Conner, 1998).
Since the striatum is the main input nucleus of the
basal ganglia and since the SNr and Globus pallidus
internal segment are the main output nuclei, it is
understandable that manganese accumulation in these areas
may cause basal ganglia dysfunction. Chapter 3 will provide
information about the dopamine system, because manganese
intoxication often impairs dopamine neurotransmission
within the basal ganglia. Chapter 4 will then discuss
manganese-induced alterations in basal ganglia functioning.
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CHAPTER THREE
THE DOPAMINE SYSTEM
Introduction
As previously mentioned, dopaminergic
neurotransmission is important for motor movement and
reward processes. Since the dopamine system is implicated
in both manganese toxicity and ADHD, the next section will
include a more thorough discussion of the dopamine system.
Specifically, the section will provide information about
the effects of psychostimulant drugs on the two main
dopaminergic pathways as well as dopamine-mediated
behaviors (e.g., locomotor activity, reward seeking
behaviors, and impulsivity). The last section will describe
maturation of the dopamine system.
Dopamine Receptor Classification
Originally dopamine receptors were classified by
anatomical location and function (Clark & White, 1987).
Subsequent work has categorized dopamine receptors into
families depending upon the ability of the receptor subtype
to activate the enzyme adenylyl cyclase (Clark & White,
1987; Kebabian & Caine, 1979). Di-like receptors stimulate
adenylyl cyclase activity, while D2-like receptors either
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inhibit or are unlinked to adenylyl cyclase activity (Clark
& White, 1987; Kebabian & Caine, 1979). On this basis, two
basic dopamine receptor families have been classified: the
Dj-like family, which consists of the Di and D5 subtypes;
and the D2-like family, which consists of the D2, D3, and D4
receptor subtypes (Clark & White, 1987). Di-like receptors
are located on postsynaptic terminals, whereas D2-like
receptors are present on presynaptic and postsynaptic
terminals (Clark & White, 1987).
Dopaminergic Drugs
Psychotropic drugs that enhance the function of a
neurotransmitter system are considered agonists; whereas,
antagonists attenuate the effects of endogenous
neurotransmitters. Dopamine agonist drugs work by either
directly stimulating receptors or by indirectly altering
cellular processes in a way that increases the amount of
endogenous neurotransmitter in the synaptic cleft.
Amphetamine, cocaine, and methylphenidate are indirect
dopamine agonists, although their mechanisms of action
differ. Amphetamine increases extracellular dopamine by
reversing the direction of the dopamine transporter, thus
increasing the release of free-floating dopamine from the
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presynaptic terminal (Heikkila, Orlansky, Mytilineou, &
Cohen, 1975; Jones, Gainetdinov, Wightman, & Caron, 1998;
Sonders, Zhu, Zahniser, Kavanaugh, & Amara, 1997). Cocaine
and methylphenidate increase extracellular dopamine levels
by blocking the dopamine transporter, thus preventing the
removal of dopamine from the synaptic cleft (Kimko, Cross,
& Abernethy, 1999; Kuhar, Ritz, & Boja, 1991; Ritz, Lamb,
Goldberg, & Kuhar, 1987; Volkow et al., 1995).
Direct dopamine receptor agonists alter dopaminergic
functioning by directly stimulating pre- and postsynaptic
receptors. For example, SKF 38393 and quinpirole
selectively stimulate Di-like and D2-like receptors,
respectively. In contrast, direct dopamine receptor
antagonists block the receptor, which prevents endogenous
or exogenous ligands from stimulating the receptor complex
Selective receptor antagonists exist for both the Di-like
(e.g., SCH 23390) and D2-like (e.g., sulpiride) receptor.
Dopamine Pathways
Behavioral responses to dopaminergic drugs are
mediated by the nigrostriatal pathway and the
mesocorticolimbic pathway. Drugs that increase dopamine
levels in the synapse (i.e., indirect agonists) initiate
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both locomotor activity and reward seeking behaviors (Cho
et al., 1999; Costall et al., 1975; Wise & Bozarth, 1987;
Wise & Hoffman, 1992). Conversely, drugs that block
dopaminergic functioning decrease motoric functioning and
inhibit reward processes (Arnt, 1987; Josselyn, Miller, &
Beninger, 1997; Miller, Wickens, & Beninger, 1990; Wise &
Rompre, 1989). The nigrostriatal pathway is most commonly
associated with intense and perseverative motoric effects
of dopaminergic drugs, whereas the mesocorticolimbic
pathway is most commonly associated with the rewarding
properties of dopaminergic drugs (Arnt, 1987; Wise &
Bozarth, 1987).
Nigrostriatal Dopamine Pathway
The nigrostriatal dopamine pathway is part of the
basal ganglia and consists of cell bodies located in the
substantia nigra and projecting to the striatum. This
pathway is primarily associated with motor movement (Arnt,
1987), because deterioration of the nigrostriatal pathway
impairs motor function and results in the behavioral
abnormalities associated with Parkinson's disease (e.g.,
tremor, rigidity, and bradykinesia) (Caine, Chu, Huang, Lu,
& Olanow, 1994; Carey, 1986; Goldberg et al., 2003; Olanow
et al., 1996). Not surprisingly, blocking dopamine
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transmission or reducing dopamine levels in the striatum
decreases motor activity. For example, depleting vesicular
stores of dopamine with reserpine reduces spontaneous
locomotor activity and stereotypy (Florin, Kuczenski, &
Segal, 1995). Additionally, dopamine receptor antagonists
block hyperactivity induced by systemic or intrastriatal
injections of direct and indirect dopamine agonists
(Costall & Naylor, 1976; Fontana, Post, Weiss, & Pert,
1993; Levin, See, & South, 1989).
Indirect dopamine agonists differentially induce
locomotor activity and stereotypical responding depending
on drug dose (Cho et al., 1999; Costall et al., 1975; Segal
& Kuczenski, 1997). At low doses, cocaine and amphetamine
increase locomotor activity due to increased dopamine
release in the nucleus accumbens (Dickson, Lang, Hinton, &
Kelly, 1994; Mele, Thomas, & Pert, 1998). On the other
hand, acute treatment with a high dose of cocaine or
amphetamine increases dopamine release in the striatum and
produces stereotypy (Dickson et al., 1994; Waszczak,
Martin, Boucher, Zahr, Sikes, & Stellar, 2001). Taken
together, these findings indicate that low doses of an
indirect agonist initially increases dopaminergic
transmission in the mesolimbic pathway; whereas, high doses
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preferentially activate the nigrostriatal dopamine system
(Dickson et al. , 1994; Mele et al., 1998; Stahl, Ferger, &
Kuschinsky, 1997; Waszczak et al., 2001).
Direct dopamine agonists are also capable of
increasing locomotor activity and inducing stereotypy
(Defts & Kelly, 1990; Einat & Szechtman, 1993; Molloy &
Waddington, 1987; Starr, 1988; Van Hartesveldt, Cottrell,
Potter, & Meyer, 1992). For example, the Di-like receptor
agonist SKF 38393 increases sniffing, rearing, and
locomotion of rats habituated to the testing environment
(Molloy & Waddington, 1987); whereas, stimulation of D2-like
receptors with quinpirole increases locomotor activity
(Einat & Szechtman, 1993; Van Hartesveldt et al., 1992).
Combined treatment with both SKF 38393 and quinpirole
induces intense stereotypies (Defts & Kelly, 1990; Molloy &
Waddington, 1987; Starr, 1988). Not surprisingly, D2-like
receptor antagonists block quinpirole-induced behaviors and
Di-like receptor antagonists block SKF 38393-induced
behaviors (Defts & Kelly, 1990; Levin, See, & South, 1989;
Starr, 1988; Storey, Middlemiss, & Reavill, 1995; White,
Bednarz, Wachtel, Hjorth, & Brooderson, 1988). The Di-like
receptor antagonist SCH 23390 also attenuates both D2-like
agonist-induced behaviors, suggesting that the Di-like
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receptor has a "permissive" or "enabling" role in dopamine
transmission (Dali'Olio, Roncada, Vaccher, Gandolfi, &
Montanaro, 1989; Defts & Kelly, 1990; Molloy & Waddington,
1987; Starr, 1988; White et al., 1988).
Mesocorticolimbic Dopamine Pathway
The mesocorticolimbic dopamine pathway is composed of
dopaminergic cell bodies located in the ventral tegmental
area and projecting to the nucleus accumbens and prefrontal
cortex (see Figure 2) (Ikemoto & Panksepp, 1999; Oades &
Halliday, 1987; Ungerstedt, 1971). Accumbal output neurons
project from the nucleus accumbens to the Globus pallidus
internal segment, and then from the Globus pallidus
internal segment to the ventral tegmental area (McBride,
Murphy, & Ikemoto, 1999; Pierce & Kalivas, 1997); whereas,
cortical output neurons project from the frontal cortex to
the nucleus accumbens and ventral tegmental area. Thus, the
ventral tegmental area, nucleus accumbens, Globus pallidus
internal segment, and frontal cortex make up the primary
sites mediating the reinforcing properties of dopaminergic
drugs (Ikemoto & Panksepp, 1999; McBride et al., 1999;
Pierce & Kalivas, 1997). Drug-induced activation of this
neural system is typically associated with subjective
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Figure 2. Schematic representation of mesocorticolimbic 
system.
Abbreviations: GPi, globus pallidus internal segment.
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feelings of reward and increased behavioral activity (Wise
& Bozarth, 1987; Wise & Hoffman, 1992).
Several different behavioral paradigms demonstrate
that the mesocorticolimbic system mediates the rewarding
properties of direct and indirect dopamine agonists. These
paradigms include drug self-administration, locomotor
activity, conditioned place preference (CPP), and schedule-
controlled operant tasks (Bardo, 1998; Ikemoto & Panksepp,
1999; Mayorga, Popke, Fogle, & Paule, 2000; Paule et al.,
1999). For example, both direct and indirect dopamine
agonists can induce CPP (Carr & White, 1983; 1996; White,
Packard, & Hiroi, 1991), and are readily self-administered
by both rodents and primates (Johanson, Balster, Bonese,
1976; Neilsen, Duda, Mokler, & Moore, 1984; Woolverton,
Goldberg, & Ginos, 1984). Conversely, destroying dopamine
terminals and cell bodies of the mesocorticolimbic pathway
attenuates self-administration of dopamine agonists, blocks
CPP, and decreases both apomorphine (a direct dopamine
agonist) and amphetamine-induced locomotor activity
(Gerrits & Van Ree, 1996; Gold, Swerdlow, & Koob, 1988;
Joyce, Stinus, & Iversen, 1983; Kelly & Iversen, 1976;
Kelly,Seviour, & Iversen, 1975; Lyness, Friedle, & Moore,
1979; Pettit, Ettenberg, Bloom, & Koob, 1984; Roberts &
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Koob, 1982; Spyraki, Fibiger, & Phillips, 1982). The latter
finding is relevant, because locomotor hyperactivity is an
indirect measure of reward (Wise & Bozarth, 1987) .
Development of the Dopamine System
The dopamine system is not adult-like at birth, but
continues to mature during the postnatal period. In
rodents, dopamine transporters, Di-like and D2-like receptor
densities increase daily throughout early postnatal
development (Galineau, Kodas, Guilloteau, Vilar, & Chalon,
2004; Murrin & Zeng, 1986; 1990; Rao, Molinoff, & Joyce,
1991; Tarazi & Baldessarini, 2000; Tarazi, Tomasini, &
Baldessarini, 1998, Zeng, Hyttel, & Murrin, 1988). The
dopamine receptor subtypes develop independently of each
other, because Di-like receptors are expressed prior to D2-
like receptors in the striatum, subtantia nigra, and globus
pallidus (Rao, Molinoff, & Joyce, 1991). During the
periadolescent period dopamine receptors are overproduced
in the striatum and prefrontal cortex, peaking by PD 40,
and are subsequently pruned back to adult levels by PD 120
(Andersen, Thompson, Rutstein, Hostetter, & Teicher, 2000;
Teicher, Andersen, & Hostetter, 1995). Dopamine
transporters, on the other hand, reach peak levels between
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PD 28 - 35 and remain constant until adulthood (Galineau,
Kodas, Guilloteau, Vilar, & Chalon, 2004; Tarazi, Tomasini
& Baldessarini, 1998).
Dopaminergic drugs have generally similar behavioral
profiles in postnatal and adult animals. For instance,
indirect dopamine agonists activate reward processes,
stimulate motor activity, and induce stereotyped behaviors
by as early as PD 2 (Barr & Lithgow, 1986; Lal & Sourkes,
1973; Lanier & Isaacson, 1977; Laviola, Dell'Omo, Alieva,
Bignami, 1992). Direct dopamine agonists (e.g., SKF 38393
and quinpirole) stimulate unlearned motor movements in
preweanling rats, while direct dopamine antagonists (e.g.,
SCH 23390 and sulpiride) reduce motor function (Camp &
Rudy, 1987; McDougall, Arnold, & Nonneman, 1990; Moody &
Spear, 1992; Sobrian, Jones, Varghese, & Holson, 2003).
Despite these behavior similarities, a number of drug
induced ontogenetic differences are evident. For instance,
younger rats are less sensitive to the cataleptic effects
of dopamine antagonists (i.e., SCH 23390 and haloperidol)
than are adult rats (Fitzgerald & Hannigan, 1989; Rowlett,
Pedigo, & Bardo, 1991). Preweanling rats (PD 11 and PD 17)
unlike adults, are also unaffected by the irreversible
dopamine receptor antagonist N-ethoxycarbonyl-2-ethoxy-l,2
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dihydroquinoline (EEDQ), since administration of EEDQ did
not alter locomotor, sniffing, or grooming responses
induced by dopamine agonist drugs (McDougall, Crawford, &
Nonneman, 1992; Mestin & McDougall, 1993).
In some cases, adult behavioral patterns are not
expressed until the third or fourth postnatal week. In
particular, quinpirole does not induce adult-typical
biphasic effects (i.e., decreased activity at low doses and
increased activity at high doses) until the third or fourth
week of postnatal development (Moody & Spear, 1992; Van
Hartesveldt, Meyer, & Potter, 1994). In addition,
progressively higher doses of SKF 38393 are required to
induce adult-typical grooming behavior in younger rats
(McDougall et al., 1990; Moody & Spear, 1992). Taken
together, these data indicate that the dopamine system is
functional during early ontogeny, however, dopaminergic
drugs are capable of inducing both quantitatively and
qualitatively different behavioral effects depending on the
age of the animal (for a review, see Spear, 1979).
Summary
Dopaminergic drugs affect both motor activity and
reward processes by altering the functioning of the
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nigrostriatal and mesocorticolimbc pathways. The
nigrostriatal pathway is generally associated with motoric
function; whereas, the mesocorticolimbic system is
associated with locomotor activation and reward processes.
The dopamine system undergoes rapid maturation throughout
the postnatal period, a process that is responsible for 
many ontogenetic differences in drug responsiveness. The
next chapter will discuss the effects of oral manganese
exposure on the dopamine system, as well as the functional
interactions between dopamine, glutamate, and GABA
neurotransmission within the basal ganglia after manganese
exposure.
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CHAPTER FOUR
MANGANESE
Introduction
The previous chapters detailed basal ganglia circuitry
as well as interactions between dopamine, glutamate, and
GABA neurons. The purpose of Chapter 4 will be to discuss
the influence of manganese on these neurotransmitter
systems. Since the behavioral manifestations of manganese
toxicity are mediated by central nervous system
functioning, it is important to understand: (1) the
mechanisms responsible for transporting manganese into the
central nervous system, (2) the actions of manganese at the
synapse, and (3) possible explanations for manganese-
induced neurotoxicity. The last part of the chapter will
detail interactions between manganese and the dopamine,
glutamate, and GABA neurotransmitter systems.
Manganese and Central Nervous 
System Functioning
The toxic effects of many compounds are often
associated with their transport mechanisms (Ingersoll,
Montgomery, & Aposhian, 1999). Therefore, it is important
to understand how manganese is transported into the central
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nervous system and throughout the brain. The brain is 
highly permeable to manganese through transferrin and non­
transferrin bound transport. In the former case, manganese
binds to transferrin and is transported across the blood-
brain barrier via transferrin receptors located on the
surface of brain capillary endothelial cells (Aschner &
Aschner, 1991; Aschner & Gannon, 1994; Davidsson,
Lonnerdal, Sandstrom, Kunz, & Keen, 1989). The greatest
percentage of manganese enters the brain independent of
transferrin binding (Takeda, Devenyi, & Connor, 1998;
Takeda, Ishiwatari, & Okada, 2000). In this case, manganese
primarily crosses into the brain as a free ion via several
different transport systems (for a review, see Takada,
2003), such as calcium channels (Drapeau & Nachshen, 1984),
or by a divalent metal transporter located on brain
capillary endothelial cells and choroidal epithelial cells
(Gunshin et al., 1997).
Once inside the brain, excess manganese accumulates in
iron-rich areas such as the striatum, nucleus accumbens,
globus pallidus, substantia nigra, ventral tegmental area
and subthalamic nucleus (Erickson, Shihabi, Aschner, &
Aschner, 2002, Fell et al., 1996; Ingersoll et al., 1999;
Komaki et al., 1999; Komura & Sakamoto, 1994; Nagatomo et
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al., 1999; Takada, 2003). Extracellular manganese is taken 
up by neurons and glial cells (Takada, 2003). Specifically, 
neurons take up transferrin-bound manganese via receptor-
mediated endocytosis and store it in synaptic vesicles
(Takada, 2003). Non-transferrin bound manganese is
sequestered in the mitochondria of astrocytes (Aschner et
al., 1992; Takada, 2003; Thorley et al., 1990). Manganese
is transported via axonal transport along GABAergic
striatonigral neurons and dopaminergic nigrostriatal
neurons (Takada, 1998). Taken together, manganese is
readily transported into and throughout the brain where it
is stored in both neurons and glial cells.
Manganese Exposure During Development
Neonatal brains accumulate manganese more extensively
than adult brains and are less efficient at maintaining
homeostatic levels (Ballatori, Miles, & Clarkson, 1987;
Doorman et al., 2000; Fechter, 1999; Kostial, Kello, Jugo,
Rabar, & Maljkovic, 1978; Rehnberg, Hein, Carter, & Laskey,
1980; Takada, Ishiwatari, & Okada, 1999). A possible
explanation for excess manganese accumulation is that the 
biliary system of neonatal rats has not fully developed, 
thus preventing manganese from being excreted in bile
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(Ballatori et al., 1987; Miller, Cotzias, & Everet, 1975).
Alternatively, neonatal rats may have an underdeveloped
gastrointestinal tract that potentiates manganese
absorption (Kostial et al., 1978; Rehnberg, Hein, Carter, &
Laskey, 1985). Elevated blood transferrin levels in
neonatal rats may also have an impact (Roskams & Connor,
1994), because increased manganese transport across an
incomplete blood-brain barrier would result in excess brain
manganese (Miller et al., 1975).
Manganese, Synaptic Transmission, 
and Neurotoxicity
The previous sections demonstrated that manganese can
accumulate in both neurons and glial cells, with the effect
being magnified in young rats. Excess manganese can
interfere with synaptic transmission through various
mechanisms. First, manganese located in the synaptic cleft
may modulate the release of glutamate, aspartate, and GABA
from neuron terminals (Tanaka, 2002). Second, manganese can
potentiate neurotransmitter release by substituting for
calcium in the exocytotic process (Drapeau & Nachshen,
1984). Third, chronic manganese increases the frequency and
amplitude of spontaneous excitatory postsynaptic potentials
(Centonze, Gubellini, Bernardi, & Calabresi, 2001) . Fourth,
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manganese potentiates glutamate-induced activation of NMDA 
receptors located on nigrostriatal dopamine terminals
(Cuesta de Di Zio et al., 1995). Taken together, it is
clear that manganese can alter neurotransmission of
dopamine, glutamate, and GABA neurons in multiple ways.
Although it is known that manganese disrupts
neurotransmission, the precise mechanism by which manganese
causes neuronal damage is uncertain. Even so, most
researchers studying manganese toxicity have focused on
three potential mechanisms involving astrocytes (Aschner et
al., 1992; Hazell, 2002), extracellular glutamate (Chen &
Liao, 2002), and oxidative stress (Chen & Liao, 2002).
Astrocytes may be responsible for manganese-induced
neurotoxicity, because mitochondria in glial cells store
excess manganese (Aschner et al., 1992; Tholey et al.,
1987). The excess manganese may disturb astrocytic
functioning, thus preventing astrocytes from providing
neurons with the necessary substrates for energy and
neurotransmitter metabolism (Hazell, 2002; Tomas-Camardiel
et al., 2002; Zwingmann, Leibfritz, & Hazell, 2003).
An additional possibility is that manganese may
initiate excitotoxicity by indirectly increasing
extracellular glutamate. Evidence supporting this idea
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includes the finding that manganese treatment decreases the
uptake of glutamate in cultured astrocytes, thereby
increasing extracellular glutamate (Chen & Liao, 2002) .
Moreover, intrastriatal injections of manganese cause
lesions similar to those produced by N-methyl-D-aspartate
(NMDA) agonists (Brouillet, Shinobu, McGarvey, Hochberg, &
Beal, 1993). The latter finding is more than coincidental,
because it is possible to prevent manganese-induced lesions
by either destroying corticostriatal glutamatergic input
fibers or pretreating rats with NMDA receptor antagonists
(Brouillet et al., 1993).
Lastly, it is possible that manganese can cause
neurotoxicity by inducing oxidative stress and free radical
formation (Chen & Liao, 2002; Desole et al., 1995; Dobson
et al., 2003). Both of these processes can be initiated by
excess amounts of extracellular dopamine and glutamate,
which is characteristic of early manganese poisoning
(Chandra & Shukla, 1981; Chen & Liao, 2002; Desole et al.,
1995; Dorman et al., 2000). More specifically, dopamine is
catabolized through oxidation, thus increasing free radical
formation (Cadet & Brannock, 1998). Consequently, free
radicals stimulate the release of additional glutamate
which potentiates glutamate excitotoxicity (Cadet &
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Brannock, 1998; Wolf, Xue, Li, & Wavak, 2000).
Additionally, manganese directly induces the oxidation of 
dopamine, resulting in additional oxidative damage (Chen &
Liao, 2002; Desole et al., 1995; Takeda, 2003).
Manganese and Neurotransmitter Systems
Dopamine
Manganese affects dopamine levels complexly, depending
upon the length of exposure and the age of the animals. 
Exposing male rats to manganese (1 mg/ml of water) for 15, 
30, 60, or 240 days increased striatal dopamine levels;
whereas, exposing rats to the same dose for 300 and 360
days reduced striatal dopamine levels (Chandra & Shukla,
1981). Consistent with the latter finding, chronic exposure
to manganese (2 g/kg of food) for 365 days decreased
striatal dopamine (Komura & Sakamoto, 1992). Taken
together, these findings suggest that manganese exposure of
less than 300 days increases striatal dopamine levels,
whereas manganese exposure for more than 300 days is
associated with striatal dopamine depletions (Chandra &
Shukla, 1981). In contrast, a number of other researchers
have reported that even a brief exposure to manganese can
decrease dopamine levels. For example, subchronic exposure
43
to manganese (100 mg/kg orally twice a day for 7
consecutive days) decreased dopamine levels in the
brainstems of 90- and 120-day-old rats (Desole et al.,
1994a), and decreased striatal dopamine levels in 120-, but
not 90-, day-old rats (Desole et al., 1994b).
The effects of manganese exposure on preweanling rats
is even more uncertain, because neonatal manganese exposure
has been reported to increase (Dorman et al., 2000),
decrease (Tran, Chowanadisai, Crinella, Chicz-DeMet, &
Lonnerdal, 2002; Tran, Chowanadisai, Lonnerdal, Le, Parker,
Chicz-DeMet, & Crinella, 2002), or not affect dopamine
levels (Kontur & Flechter, 1985; Pappas et al., 1997) .
Differences in age, dose, and type of dosing method may
account for these discrepant results. For example, dopamine
levels were enhanced after high-dose oral exposure (25 or
50 mg/kg/day) on PD 1-21 (Dorman et al., 2000), but not
after low-dose oral exposure (25 or 50 pg per day) on the
same days (Kontur & Flechter, 1985). Age may also influence
neurotoxicity because low-dose oral manganese treatment
(250 or 500 pg per day) on PD 1-21 resulted in decreased
striatal dopamine levels when assayed at PD 40 or PD 62,
but not at PD 21 (Kontur & Flechter, 1985; Tran,
Chowanadisai, Crinella, Chicz-DeMet, & Lonnerdal, 2002;
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Tran, Chowanadisai, Lonnerdal, Le, Parker, Chicz-DeMet, &
Crinella, 2002). Interestingly, striatal dopamine levels
were not affected when manganese was administered in
drinking water prenatally, postnatally, or during early
adolescence (Pappas et al., 1997).
In addition to altering dopamine levels, manganese
affects the functioning of dopamine autoreceptors, and
presynaptic and postsynaptic D2-like receptors. Manganese
disrupts the functioning of dopaminergic autoreceptors in
the striatum resulting in a loss of autoreceptor control
over dopamine release (Cuesta de Di Zio, Gomez, Bonilla, &
Suarez-Roca, 1995). Additionally, manganese-exposed rats
exhibit enhanced striatal D2-like receptor binding without
any observable changes in dopamine levels or dopamine
metabolites (Seth & Chandra, 1984). This effect is only
seen in adult rats, because neonatal manganese exposure
reduces striatal D2-like receptor binding (Seth & Chandra,
1984). Manganese also alters the functioning of D2-like
dopamine receptors in the striatum, because quinpirole-
induced excitatory postsynaptic potentials were depressed
in manganese-treated rats (Calabresi et al., 2001).
Manganese may damage dopamine transporters. In
addition to removing endogenous dopamine and reactive
45
dopamine metabolites from the synaptic cleft, dopamine 
transporters bring exogenous compounds into the synaptic
terminal, which renders the dopamine transporter vulnerable
to damage by multiple toxins (Miller, Gainetdinow, Levy, &
Caron, 1999). In particular, it is known that manganese is
capable of entering the neuron via dopamine transporters,
because cocaine pretreatment blocks manganese absorption
(Ingersoll, Montgomery, & Aposhian, 1999). Early manganese
exposure may increase the vulnerability of the dopamine
transporter and cause damage to dopamine nerve terminals.
Consistent with this idea, neonatal exposure to
environmental toxins and stimulant drugs affects dopamine
transporters. Specifically, cocaine and heptachlor increase
dopamine transporter binding, whereas neonatal exposure to
PCBs reduce the number of dopamine transporters (Caudle,
Richardson, & Miller, 2004; Fang, & Ronnekleiv, 1999;
Purkerson-Parker, McDaniel, & Moser, 2001; Richardson, &
Miller, 2004). It has yet to be determined if early
manganese exposure causes lasting changes to dopamine
transporters that persist into adulthood.
Glutamate and y-aminobutyric Acid
Previous chapters discussed how dopamine, glutamate,
and GABA neurons interact in the basal ganglia. Therefore,
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it is not surprising that manganese alters glutamate and
GABA system functioning, as well as dopaminergic
functioning. Several research reports indicate that GABA
neurotransmission is altered by manganese exposure
(Bonilla, 1978; Erikson & Aschner, 2003; Gianutsos &
Murray, 1982; Gwiazda, Lee, Sheridan, & Smith, 2002; Lipe,
Duhart, Newport, Slikker, & Ali, 1999). Specifically, long­
term exposure to high doses of manganese in drinking water
(10 mg/ml for 60 days), food (4% of total diet for 180
days), or subcutaneous injection (80 mg/kg, alternating
days for 3 weeks) enhanced GABA levels in the striatum,
while reducing dopamine content (Bonilla, 1977; Gianutsos &
Murray, 1982). Consistent with these findings, repeated
treatment with low doses (4.8 mg/kg, 3 times a week for 5
weeks) of manganese increased striatal GABA levels, while
leaving dopamine unaffected (Gwiazda, Lee, Sheridan &
Smith, 2002). However, the effects of manganese are not
uniform, because a manganese regimen of 6 mg/kg (for 30
consecutive days) caused a decrease in whole brain GABA
levels (Chandra, Malhotra, & Shulka, 1982). Likewise,
manganese (200 nM) perfused into the striatum and
hippocampus during in vivo microdialysis also reduced GABA
concentrations (Takeda, Sotogaku, & Oku, 2002, 2003) . When
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these results are considered together it appears that
manganese differentially affects GABA neurotransmission 
depending on route of administration, dose, and brain areas
investigated.
Researchers have also examined the effects of
manganese on glutamate neurotransmission. This is of
particular importance because extracellular glutamate
causes excitotoxicity, which is one of the mechanisms
responsible for manganese-induced neurotoxicity (Brouillet
et al., 1993). Specifically, manganese increases
extracellular glutamate by altering the rate of glutamate
uptake by astrocytes (Chen & Liao, 2002; Erikson & Aschner,
2002). In particular, manganese down-regulates
glutamate/aspartate (GLAST) transporter expression, thus
reducing the ability of astrocytes to remove extracellular
glutamate (Erikson & Aschner, 2002).
Manganese also disrupts glutamate and GABA
neurotransmission in developing rats (Erikson, Zakariya,
Shihabi, Aschner, & Aschner, 2002; Lipe et al., 1999).
Exposing weanling rats to high doses of manganese (20 mg/kg
via oral gavage for 30 days) increased striatal GABA levels
(Lipe et al., 1999). However, exposing iron-deficient
weanling rats to manganese (100 mg/kg in food for 42 days)
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decreased GABA levels in both the striatum and globus
pallidus, while increasing glutamate in the cortex (Erikson
et al., 2002). In the latter study, manganese
concentrations were negatively correlated with striatal
GABA levels (Erikson et al., 2002). These manganese-induced
effects have only been observed in iron-deficient weanling
rats, so it has yet to be determined whether similar
effects will occur after neonatal or perinatal manganese
exposure in non-iron deprived rats.
Interaction Between Manganese and the Dopamine, 
Glutamate, and Y_amin°kutyric Acid
Neurotransmitter Systems
It has been well established that long-term or high-
dose exposure to manganese causes dopamine depletion in the
nigrostriatal pathway. However, prior to actual cell loss
or degradation of this pathway, neuropsychiatric symptoms
and neuromotor impairment are exhibited by humans, non­
human primates, and rodents (Aschner, 2000; Beuter et al.,
1999; Dorman et al., 2000; Mergler, 1999; Mergler et al.,
1994; Newland & Weiss, 1999; Olanow et al., 1996; Witholt,
Gwiazda, & Smith, 2000). For this reason it is possible
that the initial motor impairment occurring after manganese
exposure may be caused by GABAergic, rather than
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dopaminergic, dysfunction (Chandra, Malhotra, & Shukla,
1982; Erikson & Aschner, 2003; Gwiazda et al., 2002;
Witholt et al., 2000). In light of this, Erikson and
Aschner (2003) have suggested that disruptions of GABAergic
and glutamatergic neurotransmission may precede disruptions
of the dopaminergic system. Moreover, neurochemical
alterations of glutamate and GABA may be primarily
responsible for the behavioral manifestations of early
manganese toxicity (Erikson & Aschner, 2003). Specifically,
manganese exposure (4.8 mg/kg, 3 times a week for 5 weeks)
increased striatal GABA levels, suppressed overall motor
activity, and impaired neuromuscular coordination without
altering dopamine or dopamine metabolites (Gwiazda et al.,
2002; Witholt et al., 2000).
The interaction between the dopamine, glutamate, and
GABA neurotransmitter systems involves basal ganglia
circuitry (see Figure 3). For example, manganese increases
cortical glutamatergic input to the striatum (Brouillet et
al., 1993; Calabresi et al., 2001; Cuesta de Di Zio et al.,
1995) and decreases inhibitory GABA input to the substantia
nigra and globus pallidus (Erikson et al., 2002). Manganese
accumulation in the globus pallidus also decreases the
firing rate of GABA neurons projecting to the subthalamic
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Cortex
Figure 3. Schematic representation of basal ganglia
circuitry during manganese exposure (Adapted from Erikson & 
Aschner, 2003; Verity, 1999). Bold lines represent an 
increase in transmission; whereas, broken lines represent a 
decrease in transmission.
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nucleus (Erikson & Aschner, 2003). As a result, glutamate
neurotransmission from the subthalamic nucleus to the
substantia nigra is disinhibited (Erikson & Aschner, 2003)
In summary, high-dose or long-term manganese exposure
disrupts the functioning of dopaminergic, glutamatergic,
and GABAergic neurons. Interestingly, low-dose manganese
exposure can alter glutamate and GABA levels without
changing dopamine levels. Therefore, Erikson and Aschner
(2003) suggest that manganese-induced alterations in
glutamate and GABA neurotransmission may precede changes
involving dopamine neurons.
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CHAPTER FIVE
MANGANESE AND BEHAVIORAL ALTERATIONS
Introduction
The previous chapters described manganese toxicity in
humans, the function of the basal ganglia, dopaminergic
transmission, and the effects of manganese within the
central nervous system. Not surprisingly, manganese also
causes behavioral alterations in laboratory animals.
Chapter 5 will discuss behavioral changes in neonatal and
adult rats that result from manganese exposure.
Manganese and Locomotor Activity
Since manganese toxicity is associated with
dysfunctions of the dopamine neurotransmitter system,
research has focused on alterations in spontaneous
locomotor activity as a measure of manganese toxicity. The
effects of manganese on motoric function are not uniform,
however, because there are conflicting reports regarding
manganese exposure and locomotor activity (Dorman et al.,
2000; Normandin et al., 2002; Salehi et al., 2003). For 
example, inhaled manganese (300 pg/m3 a day for 13 weeks) 
has been alternately reported to leave motoric activity
unaffected or increase motoric activity (Normandin et al.,
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2002; Salehi et al., 2003). Likewise, spontaneous locomotor
activity has been reported to decline after exposure to 
manganese during the neonatal period or in adulthood
(Talavera, Arcaya, Giraldoth, Suarez, & Bonilla, 1999;
Torrente, Colomina, & Domingo, 2002). Conversely, locomotor
activity of 17-day-old rats has been reported to increase
after perinatal exposure to manganese (Pappas et al., 1997)
and enhanced locomotor activity was evident in adult rats
exposed to manganese during adolescence (Calabresi et al.,
2000; Nachtman, Tubben & Commissaris, 1986).
Manganese poisoning progresses in stages, so it is
possible that these discrepant behavioral effects reflect
manganese-induced changes in underlying neural systems. For
example, manganese administered in drinking water increases
motor activity during the first month of exposure, followed
by five months of no change, and then causes a decrease in
locomotor activity (Bonilla, 1984). It is possible that the
initial increase in locomotor activity is due to the
increased dopamine levels often associated with short-term
manganese exposure (Bonilla, 1984; Chandra & Shukla, 1981;
Nachtman et al., 1986). The subsequent decline in locomotor
activity is consistent with nigrostriatal dopamine
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depletions often associated with long-term exposure
(Bonilla, 1984; Chandra & Shukla, 1981).
Because manganese alters neuronal functioning at a
synaptic level, a pharmacological challenge may be
necessary to "unmask" manganese-induced motoric deficits
that are not observed during basal conditions (Adams,
Buelke-Sam, Nelson, Reiter, Sobotka, Tilson, & Nelson,
1985; Hughes & Sparber, 1978; U.S. EPA, 1995). For example,
exposing rats to manganese (10 mg/ml in drinking water)
from conception to PD 80 did not affect locomotor activity;
however, an amphetamine challenge (1 mg/kg) attenuated
locomotor activity in manganese-exposed rats (Leung et al.,
1982). In another study, amphetamine potentiated manganese-
induced locomotor activity. In particular, manganese-
exposed rats (1 mg/kg in drinking water for 14-29 weeks) 
challenged with amphetamine (1.25 mg/kg) exhibited enhanced
locomotor activity relative to saline-challenged rats
(Nachtman et al., 1986). Interestingly, this manganese-
induced effect declined in magnitude by 29 weeks and
dissipated with subsequent testing (Nachtman et al., 1986).
Taken together, these data indicate that amphetamine
differentially affects the neuronal functioning of
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manganese-exposed rats by alternately potentiating and 
suppressing dopamine-mediated locomotor activity.
Manganese and Learning
Several different learning paradigms have been used to
investigate the effects of manganese on learning and 
memory. For example, neonatal manganese exposure impaired
performance on a passive avoidance task at PD 32, but not
at PD 21, or in adulthood (Dorman et al., 2000; Torente et
al., 2002; Tran, Chowanadisai, Lonnerdal, Le, Parker,
Chicz-DeMet, & Crinella, 2002). In adult rats, manganese
also impaired the acquisition of an avoidance response to
both conditioned and unconditioned stimuli (Shukakidze,
Lazriev, & Mitagvwriya, 2003).
Manganese also influences performance on maze
learning, however the effects are dependent upon age of
exposure and manganese regimen. Rats exposed neonatally to
manganese were unaffected on the elevated plus maze, Morris
water maze, or radial arm maze (Pappas et al., 1997).
During adolescence, acquisition rates on the radial arm
maze were similar for manganese-exposed (20 mg/ml in water
for 10 weeks) and control rats, indicating that manganese
does not affect spatial learning (Calabrasi et al., 2001).
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However, manganese-exposed adolescent rats correctly
completed an eight arm radial maze faster than controls,
thus indicating that manganese causes motor impairments
rather than cognitive dysfunction (Calabrasi et al., 2001).
Adult rats exposed chronically to high doses of manganese
(20 or 50 mg/kg in drinking water for 30 days) prior to
maze training showed severe learning impairment and motoric
dysfunction on a multipath maze (Shukakidze et al., 2003).
Manganese and Functional Observational Batteries
A functional observational battery (FOB) is comprised
of a variety of assessments to evaluate developmental
landmarks, sensory and motor development, and autonomic
functioning (U.S. EPA, 1995; Verity, 1997). Exposing rats
to manganese during gestation (1 or 2 mg/kg/day, s.c.)
caused a subsequent increase in infant mortality between PD
0 and PD 4, and delayed both eye opening and incisor
eruption (Torrente et al., 2002). Manganese treatment did
not affect surface righting, although it did decrease the
latency to complete a 180° turn on a negative geotaxis task 
(Torrente et al., 2002). On an olfactory discrimination
task, manganese increased the latency for 10-day-old rats
to find their home bedding (Tran, Chowanadisai, Crinella,
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Chicz-DeMet, & Lonnerdal, 2002). Taken together, these data
indicate that early manganese exposure is capable of
interfering with normal physical, sensory, and motor
development.
While FOBs are primarily used in developmental
neurotoxicological studies, adult female rats exposed 
chronically to low doses of manganese (4.8 mg/kg, 3 days a
week for 5 weeks) exhibited increased motor activity,
rearing, balance beam falls and general balance impairment,
as well as gait abnormalities and enhanced behavioral
arousal (Witholt, Gwiazda, & Smith, 2000). In contrast,
adult male rats exposed to manganese (0, 25, or 50 mg/kg)
for 18 consecutive days did not show any differences on a
FOB (Dorman et al., 2000). Taken together, these results
indicate that manganese exposure regimen, sex, and age at
testing may impact the behavioral manifestations of
manganese toxicity.
Summary
This chapter detailed behavioral alterations that
result from manganese exposure. The most intriguing
findings include: 1) the effects of early manganese
exposure (gestational through adolescents) on physical,
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sensory, and motor development, and 2) manganese-induced
changes in responsiveness to dopamine agonist drugs.
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CHAPTER SIX
DIFFERENTIAL REINFORCEMENT OF
LOW RATES OF RESPONDING
Introduction
Schedule controlled operant behaviors are often used
to assess learning and memory processes. Performance on
these tasks depends on training and motivational variables
which may be disrupted by environmental neurotoxicants
(U.S. EPA, 1995). Alterations of typical response patterns
associated with specific reinforcement schedules are
potential evidence of a neurotoxic effect (U.S. EPA, 1995)
These alterations in operant responding may include
increases in overall response rates, temporal processing,
and response distributions. The differential reinforcement
of low rate responding (DRL) task is a response contingent
behavioral task designed to assess both impulsivity and
temporal processing. The next chapter will provide
information about the DRL task, neural substrates involved
in' DRL performance, and the role of dopamine in DRL
performance.
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Differential Reinforcement of 
Low Rates of Responding
The DRL reinforcement schedule is an interval
reinforcement schedule which requires that a specified
amount of time pass before reinforcement is available. The
DRL schedule differs from a traditional fixed interval
schedule because premature responses reset the fixed
interval. It often takes multiple trials to perform this
task accurately because there are both extinction and
partial reinforcement components to DRL learning (Reynolds,
1975; Zeigler, 1977). For example, at the beginning of
training the majority of responses are not reinforced,
therefore operant responding begins to extinguish. However,
before the behavior is extinguished, a response generated
after the fixed interval will be reinforced. This
reinforced response will generate increased responding.
This pattern will be repeated until the organism learns
that reinforcement is only available after a fixed interval
of time has passed between responses (Reynolds, 1975).
In neurotoxicity or drug studies, performance on a DRL
schedule is primarily defined by overall response rates and
response patterns. Overall response rates on a DRL schedule
can be assessed by general endpoint measurements,
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including: total bar press responses, number of
reinforcements received, and efficiency scores
(reinforcements received/bar press responses). However,
while these measures can provide general information about
performance, subtle differences in response patterns often
go unnoticed (Thompson & Grabowski, 1972). In neurotoxicity
studies, examining response patterns is important because
it is necessary to differentiate between rapid bar press
responses (burst responses) and mistimed responses.
Typically, response patterns are identified by an
analysis of inter-response-time (IRT) (Thompson &
Grabowski, 1972). IRT is the amount of time occurring
between operant responses (Thompson & Grabowski, 1972). In
an IRT analysis, operant responses are categorized into
time bins (see Figure 4). For example, bin 1 represents the
number of bar press responses occurring between 0-2 s; bin
2 represents bar press responses occurring between 2-4 s;
and bin 3 represents bar press responses occurring between
4-6 s, etc. The typical IRT distribution on a DRL
reinforcement schedule is bimodal. The first peak in the
distribution represents short IRTs (i.e., bin 1 responses).
The second peak occurs in the time bin representing
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b1 b2 b3 b4 b5 b6 b7 b8 b9 b10 b11 b12 b13 b14 b15
Distribution Of Intertrial Response Time
Figure 4. Sample of a traditional differential
reinforcement of low rates of responding (DRL) intertrial 
response time (IRT) distribution. Typical performance has a 
bimodal response pattern with peak bar press responding 
being represented in the first time bin (i.e., bi) and 
reinforcement time bin (i.e., b9).
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reinforced responses (bin 9, in this case). Alterations in
the characteristic IRT distribution of a DRL schedule may
indicate behavioral abnormalities. In particular, increased
bar presses in bin 1 is indicative of increased impulsivity
(Nalwa & Rao, 1985; 2001; Sokolowski & Salamone, 1994;
Wiley, Compton, & Golden, 2000). Additionally, changes in
the number of bar press responses occurring immediately
prior to reinforcement (i.e., bin 6-8, in this case) or
after reinforcement (i.e., bin 10-12, in this case)
indicates a disruption of temporal processing (Compton et
al., 2001; Wiley, Compton, & Golden, 2000).
Neural Substrates Involved in Differential 
Reinforcement of Low Rates of
Responding Performance
Optimal performance on the DRL task requires response
inhibition and accurate timing ability, both of which
involve corticostriatal circuitry. Response inhibition is
mediated by the prefrontal cortex, since damage to this
area typically increases impulsive responding (Broersen &
Uylings, 1999; Christakou, Robbins, & Everitt, 2001;
Granon, Hardouin, Courtiere, & Poucet, 1998). Not
surprisingly, lesions to the prefrontal cortex and striatum
increase impulsive responding on a DRL schedule (Dunnett &
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Iverson, 1982; Kolb, Nonneman, & Singh, 1974; Nalwa & Rao,
1985, 2001; Numan, Seifert, & Lubar, 1975; Rosenkilde &
Divac, 1975; Schmaltz & Isaacson, 1967). Taken together,
these studies imply that intact corticostriatal circuitry
is necessary to inhibit impulsive responding on a DRL task.
DRL performance also requires accurate estimation of
time duration and this complex process involves basal
ganglia-thalamocortical circuitry (Matell & Meek, 2000;
Meek, 1996; Meek & Benson, 2002). Human neuroimaging
studies show increased activation of basal ganglia-
thalamocortical circuitry during the performance of timing
tasks (Rao, Harrington, Haaland, Bobholz, Cox, & Binder,
1997; Rao, Mayer, & Harrington, 2001). Within the basal
ganglia, the nigrostriatal pathway is particularly
important because dopamine cell loss in the substantia
nigra disrupts temporal processing (Malapani, Rakitin,
Levy, Meek, Deweer, Dubois, & Gibbon, 1998). Since DRL
performance requires both response inhibition and temporal
processing, it is not surprising that the striatum mediates
DRL performance via cortical connections (Neil, 1967).
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The Role of Dopamine in Differential 
Reinforcement of Low Rates of
Responding Performance
The dopamine system appears to be important for DRL
performance because enhancing or depressing dopamine
neurotransmission alters overall response rates and
temporal processing. Specifically, 6-OHDA lesions of the
frontal cortex increases impulsive responding, as indicated
by an increase in bin 1 responses on the DRL task
(Sokolowski & Salamone, 1994). Likewise, 6-OHDA lesions of
the striatum cause both an increase in impulsive responding
(i.e., bin 1 responses) and a decrease in overall
efficiency scores (Dunnett & Iverson, 1982). Dopamine
agonists speed up DRL performance (i.e., they shift the
peak IRT bin to the left), while dopamine antagonists slow
down DRL performance (i.e., they shift the peak IRT bin to
the right) (Paule et al., 1999). More precisely, treatment
with various indirect dopamine agonists (i.e.,
methamphetamine, amphetamine, and methylphenidate)
decreases efficiency scores, increases the number of short
IRTs, and increases overall responses (Bizot, 1998; Emmett-
Oglesby, 1980; Paule et al., 1999; Sabol, Richards, & Yung,
2000; Seiden, Andresen, & Mac Phail, 1979). These effects
appear to be mediated by dopamine receptors located in the
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striatum (Neil, 1967). In contrast, dopamine antagonists
(e.g., haloperidol, clozapine, and pimozide) decrease
response rates, which results in longer IRTs (Britton &
Koob, 1989; Compton et al., 2001; Seiden, Dahms, &
Shaughnessy, 1985; Wiley et al., 2000).
Differential Reinforcement of Low Rates of 
Responding Performance and
Environmental Toxins
The adverse effects of environmental toxins can be
identified using the DRL task. Specifically,
organophosphates, trimethyltin, and lead acetate all
disrupt DRL performance (Bizot, 1998; Dietz, McMillan,
Grant, & Kimmell, 1978; McDonough, Smith, & Smith, 1986;
Rice, 1992; Rice, & Gilbert, 1985). In the former case, the
number of overall responses and the number of
reinforcements earned on the DRL task were reduced after
exposure to organophosphates (Bizot, 1998; McDonough et
al., 1986; Wenger et al., 1985). Likewise,.trimethyltin,
which impairs cellular functioning, transiently alters DRL
performance at low doses and permanently decreases DRL
responding at high doses (Wenger et al., 1985; Woodruff,
Baisden, & Nonneman, 1991). Lead acetate, a mineral that
alters dopaminergic functioning,
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also alters DRL
performance in rodents and non-human primates (Dietz et
al., 1978; Jason, & Kellog, 1981; Rice, 1992; Rice, &
Gilbert, 1985). In particular, neonatal lead exposure
increases the number of bar presses with short IRTs and
decreases the number of reinforcements earned (Dietz et
al., 1978; Rice, 1992; Rice & Gilbert, 1985). Therefore,
while no studies have investigated the ability of manganese
to alter DRL performance, there is an abundance of evidence
suggesting that a variety of neurotoxicants, some of which
affect the dopamine system, alter DRL performance.
Summary
The DRL task is a sensitive measure of impulsivity and
temporal processing (Paule et al., 1999; Reynolds, 1975;
Sokolowski & Salamone, 1994; Thompson & Grabowski, 1972).
Intact functioning of the prefrontal cortex and basal
ganglia is necessary for successful performance on the DRL
task, thus this task is sensitive to alterations of
dopamine neurotransmission (Compton et al., 2001; Neil,
1967; Sokolowski & Salamone, 1994). Not surprisingly,
neurotoxin-induced alterations of the dopamine system
adversely affect DRL performance.
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CHAPTER SEVEN
CONDITIONED PLACE PREFERENCE
Introduction
Chapter 6 discussed the use of the DRL task to measure
neurotoxicity because environmental toxins often affect
impulsivity and temporal. processing. It is also possible
that environmental neurotoxicants are capable of disrupting
reward functioning. At present, it is uncertain whether
neonatal manganese exposure alters the rewarding properties
of psychostimulant drugs. Chapter 7 will discuss the CPP
paradigm, the neural substrates mediating cocaine place
preference, and the effects of environmental toxins on CPP.
Conditioned Place Preference
In the CPP paradigm, the animal learns an association
between a particular compartment of a testing apparatus and
the rewarding properties of food, water or a drug (Beninger
& Miller, 1998; Wise & Hoffman, 1992). In most CPP studies
the environmental context becomes associated with the
rewarding aspects of a particular drug. The associations
formed during the CPP procedure are based on Pavlovian
learning principles. Specifically, a previously neutral
stimulus (i.e., the testing compartment) is paired with an
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unconditioned stimulus (i.e., the drug). After repeated
pairings of the testing compartment (conditioned stimulus)
with the drug (unconditioned stimulus), the animal forms an
association between the two. In the case of CPP, the animal
prefers to spend time in the drug-paired compartment
because the test compartment has come to elicit feelings of
reward or drug craving (Beninger & Miller, 1998; Wise &
Hoffman, 1992).
Neural Substrates Involved in Cocaine-Induced 
Conditioned Place Preference
Cocaine- and amphetamine-induced CPP involves multiple
neural substrates including the nucleus accumbens, ventral
tegmental area, globus pallidus, and prefrontal cortex (for
a review, see Bardo, 1998). Together these brain areas
compose the mesolimbic, mesocortical, and mesopallidal
dopamine circuits that were detailed in Chapter 3. The CPP
paradigm has provided evidence implicating each of these
circuits with the reinforcing properties of dopaminergic
drugs.
Mesolimbic Circuitry and Conditioned Place 
Preference
The mesolimbic dopamine pathway consists of
dopaminergic cell bodies located in the ventral tegmental
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area and projecting to the nucleus accumbens (Ikemoto &
Panksepp, 1999; Oades & Halliday, 1987; Ungerstedt, 1971).
Microinjecting both direct (SKF 38393 and quinpirole) and
indirect (amphetamine) dopamine agonists into the nucleus
accumbens increases the amount of time rats spend in the
drug-paired compartment (Carr & White, 1983; 1986; White,
Packard, & Hiroi, 1991). Not surprisingly, intra-accumbens
microinjections of Di-like and D2-like antagonists (SCH
23390 and sulpiride) block amphetamine-induced CPP (Hiroi &
White, 1991). Conversely, cocaine-induced CPP is only
blocked when a Di-like receptor antagonist (SCH 23390), and
not a D2-like receptor antagonist (sulpiride), is
microinjected into the nucleus accumbens (Baker, Fuchs,
Specio, Khroyan, & Neisewander, 1998; Baker, Khroyan,
O'Dell, Fuchs, & Neisewander, 1996). Therefore, Di-like
receptor stimulation in the nucleus accumbens is more
important for the rewarding properties of cocaine CPP than
is D2-like receptor stimulation (Baker et al., 1996, 1998).
Mesocortical Circuitry and Conditioned Place 
Preference
The mesocortical dopamine pathway is composed of
dopaminergic cell bodies located in the ventral tegmental
area and projecting to the prefrontal cortex (Ikemoto &
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Panksepp, 1999; Oades & Halliday, 1987; Ungerstedt, 1971).
Several lines of evidence suggest that the prefrontal
cortex is associated with the rewarding properties of
cocaine. First, rats will self-administer cocaine directly
into the prefrontal cortex (Goeders & Smith, 1983, 1986).
Second, destruction of dopamine terminals in the prefrontal
cortex prevents a CPP response to cocaine, but not
amphetamine (Bardo, 1998; Carr & White, 1986; Isaac,
Nonneman, Neisewander, Landers, & Bardo, 1989; McBride,
Murphy, & Ikemoto, 1999). Taken together, these data
suggest a dissociation between those brain areas mediating
the effects of psychostimulant drugs, with the prefrontal
cortex being more important for cocaine CPP, whereas the
nucleus accumbens is critical for amphetamine CPP (Carr &
White, 1986; Isaac et al., 1989).
Mesopallidal Circuitry and Conditioned Place
Preference
Emerging research suggests that mesopallidal
circuitry may also be important for the rewarding actions
of psychostimulant drugs (Berridge, 2003; Gong, Neill, &
Justice, 1996; McBride et al., 1999; Panagis et al., 1997).
This pathway consists of dopamine cell bodies located in
the ventral tegmental area and projecting to the globus
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pallidus (Klitenick, Deutch, Churchill, & Kalivas, 1992). 
Lesions to the globus pallidus attenuate the reinforcing
effects of cocaine and food reward (Gong et al., 1997;
McAlonan, Robbins, & Everitt, 1993). Additionally,
microinjecting amphetamine and cocaine into the globus
pallidus induces CPP (Gong, Neill, & Justice, 1996). These
data are consistent with electrophysiology studies showing
that pallidal neurons are responsive to systemic cocaine
administration independent of activation of the nucleus
accumbens (Johnson & Napier, 1996) .
Conditioned Place Preference and 
Environmental Toxins
Very few studies have investigated the effects of
environmental toxins on reward processes. Available studies
indicate that exposure to environmental toxins can lead to
changes in the rewarding properties of psychostimulant
drugs. For example, cadmium attenuates place preference
conditioning to low, but not high, doses of cocaine and.
apomorphine (Miller, Palme, Najvar, Caudill, & Nation,
1999). In addition, perinatal lead exposure attenuates
cocaine- and morphine-induced CPP in adult rats (Miller,
Nation, & Bratton, 2000; Valles, Cardon, Heard, Bratton, &
Nation, 2003). Taken together, these studies indicate that
73
environmental toxins are capable of causing long-lasting
alterations in reward function.
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CHAPTER EIGHT
THE EFFECTS OF NEONATAL MANGANESE EXPOSURE ON
IMPULSIVITY, UNLEARNED MOTORIC FUNCTION,
AND REWARD
Summary
Manganese is an essential trace mineral that can
damage the central nervous system. There is increasing
evidence that children may be particularly prone to
manganese neurotoxicity, because immature brains accumulate
manganese more extensively than adult brains and are less
efficient at maintaining homeostatic levels (Takada,
Ishiwatari, & Okada, 1999). Therefore, manganese exposure
during development may amplify the risk of neuronal damage
(Cawte, 1985; Lonnerdal, 1994; Weiss, 1999). Of special
concern are infant formulas, because manganese levels in
commercially available infant formulas may be sufficient to
cause lasting behavioral deficits and neurological
dysfunctions that are similar to symptoms observed in ADHD
(Lonnerdal, 1994; Tran, Chowanadisai, Crinella, Chicz-
DeMet, & Lonnerdal, 2002; Tran, Chowanadisai, Lonnerdal,
Le, Parker, Chicz-DeMet, & Crinella, 2002). Thus, children
fed these formulas may be at risk for lasting brain changes
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that result in long-term behavioral dysfunction (Cawte,
1985; Lonnerdal, 1994; Mergler, 1999; Weiss, 1999).
Based on this rationale, I designed a series of
experiments to explore the effects of low-dose manganese
exposure on behaviors that are sensitive to disruption of
the corticostriatal pathway, and the nigrostriatal and
mesocorticolimbic dopaminergic systems. Additionally, I
investigated the effects of early manganese exposure on
developmental landmarks, sensory and motor development, and
neurochemical indices of dopamine transporters.
Experiment One
Recent research has found that moderate levels of
manganese, consistent with those found in infant formulas,
are able to produce behavioral and neurochemical
alterations in rats (Tran, Chowanadisai, Crinella, Chicz-
DeMet, & Lonnerdal, 2002; Tran, Chowanadisai, Lonnerdal,
Le, Parker, Chicz-DeMet, & Crinella, 2002). Specifically,
these reports show that manganese decreases striatal
dopamine levels and impairs performance on tasks that
assess sensory and motor development (Tran, Chowanadisai,
Crinella, Chicz-DeMet, & Lonnerdal, 2002; Tran,
Le, Parker, Chicz-DeMet, &
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Chowanadisai, Lonnerdal,
Crinella, 2002). In these studies, however, ADHD
symptomology, including impulsivity, was not measured.
Therefore, the purpose of this experiment was to
determine whether early manganese exposure affects
impulsivity of adult rats. The DRL paradigm will be used
for two reasons: First, the DRL task is a sensitive measure
of drug-induced changes in impulsivity; and, second,
alterations in dopamine system functioning are known to
affect DRL performance. Thus, if manganese enhances
impulsivity by modulating the dopamine system, the DRL task
should be sensitive to these changes.
Specifically, overall DRL performance was assessed by
examining the total number of bar press responses and
efficiency scores (reinforcement received/total responses)
of saline- and manganese-exposed rats. Impulsivity, timing,
and learning were further examined by analyzing IRT
distributions. I hypothesized that early manganese exposure
would enhance impulsivity of adult rats, as evidenced by
reduced efficiency scores, increased amounts of total
responding, bin 1 responding (responses occurring 0-2 s
after a previous bar press), and burst responding (number
of consecutive responses occurring within 1 s of the
previous bar press). Additionally, manganese-exposed rats
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should have had an increased number of responses in the
time bins preceding the reinforcement bin, indicating a
disruption of temporal processing. I also hypothesized that
manganese-exposed rats should show impairments in
acquisition (learning) of the DRL task as evidenced by
fewer reinforced responses than control rats and a slower
shift of bin responses (i.e., from early time bins to
latter time bins over training days).
Experiment Two
Several lines of evidence suggest that neonatal
manganese exposure can have deleterious behavioral and
neurochemical effects. First, early manganese exposure is
capable of impacting physical maturation, sensory, and
motor development, as well as locomotor activity (Pappas et
al., 1997; Tran, Chowanadisai, Crinella, Chicz-DeMet, &
Lonnerdal, 2002; Torrente et al., 2002). Second, neonatal
manganese exposure causes atypical responding to indirect
dopamine agonists, which is indicative of manganese-induced
neuronal impairments (Leung et al., 1982). These effects
are not uniform, however, so it is not clear if moderate
levels of manganese will induce short- or long-term changes
in motoric development, motor activity, or neuronal
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function. Third, manganese interferes with dopamine
transporter functioning (Aposhian et al., 1999).
Therefore, the purpose for this experiment was three­
fold. The first purpose was to assess the effects of early
manganese exposure on standard developmental landmarks
(e.g. physical development, motor development, sensory
function, and activity levels) during the neonatal period.
Balance and coordination was assessed during adulthood. The
second purpose was to assess the effects of early manganese
exposure on basal and cocaine-induced locomotor activity in
preweanling and adult rats. The third purpose was to assess
the effects of early manganese exposure on striatal
dopamine transporters.
I hypothesized that early manganese exposure would
delay the appearance of developmental landmarks, interfere
with neonatal sensory and motor development, and impair
balance and coordination in adulthood. I also hypothesized
that manganese-exposed rats would exhibit an attenuated
locomotor response to cocaine challenge. Finally, I
hypothesized that manganese would decrease striatal
dopamine transporter binding sites.
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Experiment Three
The rewarding properties of cocaine are mediated by
dopamine release in the nucleus accumbens, prefrontal
cortex, and globus pallidus (Bardo, 1998; Hiroi & White,
1990). This is interesting because ADHD has been
hypothesized to result from an immature reward system
(Casey et al., 1997; Johansen et al., 2002; Sagvolden et
al., 1998; Solanto et al., 1997). There are two reasons to
suspect that manganese may disrupt psychostimulant-induced
reward processes. First, manganese potentiates glutamate-
induced activation of NMDA receptors and NMDA receptors are
implicated in the acquisition of cocaine CPP (Cervo &
Samanin, 1995; Cuesta de Di Zio et al., 1995). Second,
manganese accumulates in brain areas associated with the
mesopallidal and mesolimbic reward circuits, including the
globus pallidus, the ventral tegmental area, and the
nucleus accumbens (Berridge, 2003; Fell et al., 1996; Gong,
Neill, & Justice, 1996; 1997; Komaki et al., 1999; McBride
et al., 1999; Panagis et al., 1997).
Currently, most research on neonatal manganese
exposure has focused on alterations of unlearned motor
performance, which is predominantly mediated by the
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nigrostriatal dopamine system. The effect of neonatal
manganese exposure on the mesocorticolimbic dopamine system
has not been fully explored. Therefore, the purpose of this
study is to investigate the effects of neonatal manganese
treatment on drug reward by utilizing a CPP paradigm. I
hypothesized that manganese exposure would reduce the
rewarding properties of cocaine, as evidenced by a
decreased amount of time spent in the drug-paired
compartment.
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CHAPTER NINE
GENERAL METHODS
Subj ects
Subjects were 208 male and female rats of Sprague-
Dawley descent (Harlan, San Diego), born and raised at
California State University, San Bernardino. Rats were
housed in a colony room maintained on a 12:12 light:dark
cycle at 22°-24°C. Litters were culled to 10 on postnatal
day (PD) 1, weaned on PD 24, and group housed until the
start of behavioral testing. Food and water was provided ad
lib. Rats were treated in accordance with the National
Institutes of Health guidelines ("Principles of Laboratory
Animal Care", NIH Publication #85-23) under a research
protocol approved by the Institutional Animal Care and Use
Committee of California State University, San Bernardino.
Drugs and Chemicals
Manganese chloride (Sigma Chemicals, St. Louis) was
dissolved in 10% sucrose solution and administered orally
via micropipette. (-)-Cocaine hydrochloride (Sigma) was
dissolved in saline and injected intraperitoneally at a
volume of 5 ml/kg for preweanling rats and 1 ml/kg for
adult rats.
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Statistics
Behavioral data was analyzed using repeated measures
analyses of variance (ANOVA). Both manganese condition (0,
250, 500, or 750 pig) and sex (male and female) were between
subject variables. Repeated measure variables were day,
trial, or time block depending upon the experiment and
behavioral task. Significant higher order interactions were
further analyzed using one- or two-way ANOVAs.
Neurochemical data were analyzed using nonlinear regression
to determine Bmax and K& values. Group differences were
assessed using one-way (manganese treatment) ANOVAs. All
post hoc comparisons were done using Tukey tests (p < .05).
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CHAPTER TEN
EXPERIMENT ONE: THE EFFECTS OF NEONATAL MANGANESE
EXPOSURE ON A DIFFERENTIAL REINFORCEMENT
OF LOW RATES OF RESPONSE TASK
. DURING ADULTHOOD
The purpose of Experiment 1 was to assess the effects
of neonatal manganese exposure on the impulsivity of adult
rats by using a DRL-20 task. It was predicted that early
manganese exposure would amplify impulsivity of adult rats,
as evidenced by increased amounts of total responding, bin
1 responding, and burst responding. Additionally, it was
expected that manganese-treated rats would have fewer
reinforced responses and reduced efficiency scores than
control rats.
Methods
Manganese Treatment
A total of 32 rats (n = 8 per group) were used in this
experiment. On PD 1-21, male and female rats were given
daily supplements consisting of 0, 250, 500, or 750 pig
manganese.
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Apparatus
Standard operant chambers (Coulborn Instruments,
Allentown, PA) were used. The chambers were located inside
sound attenuated cubicles and were controlled by an IBM
compatible computer interfaced with Graphic State Notation
software and data collection program. Operant chambers (30 x
30 x 25 cm) included one response lever, a house light, and
a feeder.
Procedures
On PD 83, rats began food restriction (90% of normal
body weight). On PD 90-94, rats were shaped to bar press
for food reward. On PD 95, rats began the DRL procedure.
Specifically, on PD 95 and PD 96 rats were placed on a DRL-
5 schedule of reinforcement where they must withhold a
response for more than 5 s to gain a food reward. Responses
prior to the fixed interval reset the time clock. On PD 97-
106, rats were advanced to a DRL-10 schedule for 10
consecutive days. Then for the following 30 days, rats were
trained on a DRL-20 schedule in which they received a food
reward after withholding a response for 20 s. Daily
sessions terminated after acquisition of 50 pellets or
until 50 min had elapsed.
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DRL performance was assessed using several different
measures. Total daily bar press responses, total
reinforcements earned, and efficiency scores
(reinforcements received/total responses) were used to
assess overall performance. An analysis of IRTs was used to
measure differences in overall patterns of responding.
Specifically, responses occurring prior to the 20 s
interval were recorded in ten 2-s time bins. Reinforced
responses were recorded in an eleventh time bin. Responses
occurring in the 0-2 s time bin were used as a measure of
impulsivity. Multiple rapid bar press responses occurring
within 1 s of each other were grouped and termed burst
responses.
Statistics
Total responses, efficiency scores, reinforcements
received, bin 1 responses, and burst responses were
analyzed using separate 4 x 2 x 10 (manganese condition x
sex x time block) repeated measures ANOVAs. The manganese
independent variable consisted of four levels of manganese
pretreatment (0, 250, 500 or 1000 |ig manganese per day); the
sex independent variable consisted of male and female rats;
and the repeated measure was over 30 days of DRL
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performance divided into 10 three-day time blocks. Post hoc 
comparisons were done using Tukey tests (p < .05).
Results
Differential Reinforcement of Low Rates of 
Responding: 5 - Second Delay
Early manganese exposure did not impact acquisition of
bar press shaping on an FR 1 schedule of reinforcement.
During the subsequent two days of DRL 5 training, manganese
interacted with sex to affect total number of bar press
responses [manganese x sex interaction, F(3,47)=3.09, P <
0.05]. However, post hoc comparisons using Tukey tests did
not reveal any significant differences between groups.
Additionally, when males and females were analyzed
separately, manganese did not affect total bar press
responses.
Differential Reinforcement of Low Rates of 
Responding: 10 - Second Delay
During the 10 days of DRL 10 training, manganese
exposure did not alter performance on any behavioral
measures (efficiency scores, total number of responses, or
burst responding). Additionally, manganese-induced effects
were not apparent on an analysis of inter trial response
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Figure 5. Analysis of intertrial response time (IRT) bin 
distributions of male (upper graph) and female (lower 
graph) rats (n = 6-8). Time bins (2 s) are totaled over the 
10-day testing session. Rats were pretreated with manganese 
from PD 1-21.
aSignificant difference between manganese-treated rats and 
vehicle controls (R < 0.05).
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times for male or female rats (Fig. 5). In general, male
rats (329.15 ± 24.13) bar pressed significantly more than
female rats (245.00 ± 13.79) [sex main effect
F(l,47)=10.43, P < 0.05], with this effect reaching
significance on days 1-4 [sex x day interaction,
F(9,423)=2.86, P < 0.05]. Additionally, male rats (65.71 ±
7.11) made more 1 s burst responses than female rats (42.75
± 3.59) on the DRL 10 schedule of reinforcement [sex main
effect, F(l,47)=8.77, P< 0.05].
Differential Reinforcement of Low Rates of 
Responding: 20 - Second Delay
Over 30 consecutive days of DRL 20 training,
efficiency scores did not differ according to manganese
exposure or sex. Manganese exposure also did not affect
total number of bar press responses. Overall, male rats
(234.97 ± 20.94) had more bar press responses than female
rats (183.09 ± 11.78) [sex main effect, F(l,53)=4.915, P <
0.05]. To further evaluate differences between controls and
manganese-exposed rats, interaction comparisons were
performed on total number of bar press responses. Data were
combined across manganese treatments (250, 500, and 750 pg)
and harmonic means were used to adjust for uneven sample
size. The total number of bar press responses of manganese-
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Figure 6. Mean total bar press responses (± S.E.M.) of 
adult male and female rats (n = 6-8) tested on a 
differential reinforcement (DRL) 20 s schedule for 30 
consecutive days. Rats were treated with manganese from PD 
1-21. Inset shows the average total bar press responses. 
aSignificantly different from manganese-treated rats 
(P < 0.05).
bSignificantly different from male rats (P < 0.05).
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exposed rats varied according to sex (Fig. 6, inset)
[manganese x sex interaction, F( 9, 459)=2.98, P < 0.05]. For
male rats, manganese caused a significant reduction in
total number of bar press responses across the first 12
days (time blocks 1-4) of DRL 20 testing (Fig. 6, top
graph) [manganese x time block interaction, F( 9,216)=2.75, P
< 0.05; and Tukey tests, P < 0.05]. For female rats,
manganese did not alter total bar press responses (Fig. 6,
bottom graph).
Responses occurring within 1 s of each other were
grouped and termed burst responses. Male rats (40.41 ±
7.08) made more 1 s burst responses than female rats (22.40
± 3.67) [sex main effect, F(l,47)=6.23, P < 0.05]. Burst
responses varied by manganese exposure and sex over the 30
days of DRL 20 training (Fig. 7) [manganese x sex x day
interaction, F(27,423)=1.95, P < 0.05]. Interaction
comparisons were conducted by combining manganese exposure
groups. The number of 1 s burst responses varied for
manganese-exposed rats according to sex (Fig. 7, inset)
[manganese x sex interaction, F( 1,51)=7.32, P < 0.05].
Comparisons between manganese exposed groups (250, 500, or
750 pg) and controls showed that male rats exposed to
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Figure 7. Mean (± S.E.M.) 1 s burst responses made by adult 
male and female rats (n = 6-8) tested on a differential 
reinforcement (DRL) 20 s schedule for 30 consecutive days. 
Rats were treated with manganese from PD 1-21. Inset shows 
the average total number of 1 s burst responses. 
aSignificantly different from manganese-treated rats 
(P < 0.05) .
bSignificantly different from male rats (P < 0.05).
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manganese committed fewer 1 s burst responses than controls
during time blocks 1-6 (Fig. 7, top graph) [manganese x
time block interaction, F(9, 216)=4.32, P < 0.05; and Tukey
tests, P < 0.05]. The 1 s burst responses of female
manganese-exposed rats did not differ from vehicle-treated
rats (Fig. 7, bottom graph).
An analysis of intertrial response times showed that
differences in the bin distribution of manganese-treated
rats varied according to sex throughout the 30 days of DRL
testing (Fig. 8) [manganese x sex x response bin,
F(30,470)=2.59, P < 0.05]. For male rats, manganese reduced
bin 1 responses during time blocks 1-7 (Fig. 9)
[manganese x time block interaction, F(27,198)=5.48, P <
0.05; and Tukey tests, F<0.05]. In contrast, female rats
exposed to manganese pressed the bar more than controls
(Fig. 10, upper graph) [manganese x time block interaction,
F(27,225)=1.67, P < 0.05; and Tukey tests, P < 0.05].
Specifically, female rats pretreated with 500 pg manganese
had more bin 7 responses on days 4 - 6 (i.e., time block
2); whereas, female rats pretreated with 750 pg manganese
had more bin 7 responses than vehicle-treated rats on days
7-15 (i.e., time blocks 3-5) (Fig. 10, upper graph).
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Figure 8. Analysis of intertrial response time (IRT) 
bin distributions of male (upper graph) and female 
(lower graph) rats (n = 6-8). Time bins (2 s) are 
totaled over the 30-day testing session. Rats were 
pretreated neonatally with manganese from PD 1-21. 
aSignificant difference between manganese-treated rats 
and vehicle controls (P < 0.05).
94
400
£ 300' 00
(A
<U
(A
c
o
Q.
(A
<D06
200-
100-
-O— Vehicle 
-k- 250 fig Manganese 
500 fig Manganese 
750 fig Manganese
T"
6
t-
8
T"
9 10
“l-
5
Blocks of Three Days
Figure 9. Mean bar 
the 0-2 s time bin
(± S.E.M.) press responses occurring in 
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Figure 10. Mean (± S.E.M.) number of bar press responses of 
female rats (n = 7-8) occurring in bin 7 (upper graph) and 
bin 11 (lower graph). The 30 days of testing are divided 
into ten 3-day blocks. Rats were pretreated with manganese
(0, 250, 500, or 750 jxg) on PD 1-21.
aSignificantly different from vehicle-treated rats 
(P < 0.05).
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Manganese exposure also affected the number of reinforced
responses of female rats in bin 11 [manganese x time block
interaction, F(27,225)=1.56, P < 0.05; and Tukey tests, P <
0.05]. Specifically, vehicle-exposed rats received more
reinforcements on days 10 - 12 than rats pretreated with 50
lag manganese (i.e., time block 4) (Fig. 10, lower graph) .
Discussion: Experiment One
Accurate performance on the DRL task requires precise
estimation of time duration and the ability to inhibit a
response, consequently this task is commonly considered a
sensitive measure of impulsivity (Monterosso & Ainslie,
1999; Wiley et al., 2000). In addition, the DRL task is
sensitive to alterations of the dopamine neurotransmitter
system, therefore this task can be used to assess the
effects of environmental neurotoxins on dopamine neurons.
In the current study, neonatal exposure to manganese was
evaluated on DRL 5, 10, and 20 schedules of reinforcement.
It was originally hypothesized that manganese treatment
would increase the impulsive responding of both male and
female rats. However, the pattern of results reflects an
overall reduction of responding in male rats and a subtle
response increase in female rats.
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Manganese-exposed rats were shaped over four days to 
press a lever for food reward and there were no differences 
in the ability of rats to acquire the operant response.
During DRL training, female rats made fewer non-reinforced
responses than male rats on the DRL 10 and 20 tasks. These
findings are consistent with previous studies showing
sexually dimorphic response rates on the DRL task, (van
Hest, van Haaren, & van de Poll, 1987). Moreover, the
present experiment demonstrated that neonatal manganese
exposure impacted male and female rats differently.
Specifically, manganese reduced total bar press responding,
burst responding, and bin 1 responses of adult male rats.
Female rats did not differ on these measures; however, an
analysis of the IRT bin distribution for female rats showed
that manganese exposure caused increased responses in time
bin 7 and decreased responses in time bin 11.
In the current study, manganese-exposed male rats had
fewer total bar press responses and 1 s burst responses
relative to vehicle-exposed rats. An analysis of the IRT
bin distribution demonstrated that the decrease in bar
press responding for male rats was predominately caused by
reduced responses in time bin 1. Responses occurring in the
first time bin are indicitive of the ability to delay or
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inhibit a voluntary behavior (Monterosso & Ainslie, 1999;
Wiley, Compton, & Gorden, 2000). Taken together, it appears
as if neonatal manganese treatment caused a decrease in
impulsivity. In fact, this pattern of manganese-exposed
effects is reminiscent of the behavioral response patterns
induced by dopamine antagonist drugs. Dopamine antagonists
slow down DRL performance, thus decreasing response rates
and causing longer IRTs (Britton & Koob, 1989; Compton et
al., 2001; Paule et al., 1999; Seiden, Dahms, &
Shaughnessy, 1985; Wiley et al., 2000) .
Based on these considerations, it is probable that
neonatal manganese treatment attenuates dopamine
transmission in a way that depresses motor, reward, or
attentional functioning on the DRL task. For instance, the
reduced bar press responding exhibited by manganese-treated
male rats could result from manganese-induced alterations
of the nigrostriatal dopamine pathway. Since manganese
toxicity is commonly associated with extrapyramidal motor 1
impairments, the generalized slowing of responses observed
in manganese-exposed rats could be indicative of subtle
long-term deficits in motoric ability. Similar to the
effects of dopamine antagonists, manganese-exposed rats may
have taken longer to terminate individual responses,
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thereby reducing the number of response opportunities
available during a testing session (Ettenberg, 1989) .
Decreased responses consisted primarily of rapidly executed
burst responses and responses with short IRTs (i.e., 1 s
burst and bin 1 responses), which further suggests that
manganese may cause subtle motor difficulties. Consistent
with this idea, manganese-exposed (5 and 10 mg/kg, i.p.)
adult cebus monkeys had multiple failed attempts to
complete a lever moving task on a variable ratio schedule
of reinforcement (Newland & Weiss, 1992). Moreover,
manganese exposure caused these monkeys to increase the
length of IRT's, to decrease overall responses, and to
eliminate burst responses (Newland & Weiss, 1992). Thus,
manganese-induced motor impairment is a probable
explanation for the reduced responses observed on the DRL
20 task.
Alternately, manganese may depress reward system
functioning in male rats, hence the decreased bar press
responding may reflect a lack of motivation for the food
reinforcer. Because food reward is mediated, in part, by
mesolimbic dopamine transmission (Fell et al., 1996; Gong,
Neill, & Justice, 1996; 1997; Zhang, Balmadrid, & Kelly,
2003), accumulation of manganese in the mesolimbic pathway
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may depress dopaminergic mediation of food reward. More
specifically, manganese- and vehicle-exposed rats performed 
similarly on DRL 5 and DRL 10 tasks; however the increased 
difficulty of the DRL 20 task may have revealed a reduction
in the saliency of food reward. Thus, manganese-exposed
rats may be less inclined to bar press on a more difficult
schedule of reinforcement.
Another possible explanation for the manganese-induced
reduction in bar press responses is that manganese could
have adversely affected attentional processes of male rats
(i.e., the animals were easily distracted). For example,
mesocortical dopamine transmission is important for
modulating associative processes involved in decision­
making, attentional control, and working memory, processes
collectively referred to as "executive functions" (Barkley,
2003; Sullivan & Brake, 2003). Mesocortical dopamine is
essential for an organism to focus more precisely on
specific stimuli controlling behavior at a given time
(Robbins, 2000; Sullivan & Brake, 2003). Since DRL
performance is dependent on both cortical and striatal
dopamine function, reductions in mesocortical dopamine
could adversely affect DRL performance (Neil, 1967;
Sokolowski & Salamone, 1994).
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In contrast to male rats, manganese-exposed female
rats did not show a decrease in rapidly executed burst
responses, but instead showed subtle response increases in
time bin 7. The increased responses observed prior to the
fixed interval can be explained in two ways. First,
manganese may have impaired the timing ability of female
rats. However, this is unlikely since the number of
responses in those time bins immediately prior to
reinforcement (i.e., bins 9 and 10) did not vary.
Alternately, manganese may have disrupted the ability of
female rats to adapt to the new response requirements
(i.e., a 20 s withholding period), because prior
performance on a DRL 10 schedule may have interfered with
later performance. Specifically, manganese-exposed female
rats were unable to transfer learning from a DRL 10
scheduale to a DRL 20 scheduale. For example, manganese
caused a dose-dependant increase in bar press responses
sequentially surrounding the 10 s delay (i.e., bins 5-8),
with the manganese effect reaching statistical significance
on time bin 7. The transient nature of this effect
(occurring on days 2 - 15) is suggestive of a delayed
adaptation to the new response contingency, because
performance was consistent with controls during the final
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testing sessions. The decreased number of reinforcements
earned by manganese-exposed females supports this idea,
because increased responding during the 20 s delay would
lead to a decline in the number of opportunities to earn
reinforcement. A similar response pattern was observed in
female rats exposed to polychlorinated biphenyls (PCB)
(Holene et al., 1999). Specifically, PCB-treated females
had difficulty adapting from a variable interval/extinction
paradigm to a DRL 14 task. Holene and colleagues (1999)
suggested that the PCB-exposed females exhibited a
temporary delay in acquisition of the new reinforcement
schedule.
When considered together, the differential responding
of male and female manganese-exposed rats supports previous
research demonstrating that developmental neurotoxicants
are capable of producing sex-dependant effects (Hojo et
al., 2002; Holene et al., 1999; Weiss, 2002). Because the
developing endocrine system is vulnerable to exogenous
compounds, alterations in gonadal hormones may contribute
to the disparities observed in male and female rats (Weiss,
2002). At this point, it is important to note that male
rats are particularly sensitive to neurotoxicants that
damage the nigrostriatal dopamine system (Miller, Ali,
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O'Callaghan, & Laws, 1998). This is largely attributed to
the neuroprotective effects of estrogen (Dluzen, 2000;
Miller et al., 1998). Although preweanling females have
higher concentrations of serum estradiol than males (Banu,
Govindarajulu, & Aruldhas, 2002), it is uncertain whether
these levels are sufficient to produce neuroprotective
effects during manganese exposure. Conversely, testosterone
is known to affect performance on operant tasks (van
Haaren, van Hest, & Heinsbroek, 1990; van Hest, van Haaren,
& van de Poll, 1989), so it is possible that the
differential responding of male and female rats may have
been due to the presence of testosterone rather than the
neuroprotective effects of estrogen.
In conclusion, early manganese exposure impacted the
DRL performance of adult rats. Interestingly, many of these
effects varied according to sex. These manganese-induced
effects may involve several different dopamine-mediated
systems: motor, reward, attention, and/or learning.
Nevertheless, the present results indicate that neonatal
manganese exposure has long-term behavioral consequences
when performance is assessed on a DRL task.
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CHAPTER ELEVEN
EXPERIMENT TWO: THE EFFECTS OF NEONATAL MANGANESE
EXPOSURE ON UNLEARNED BEHAVIORS AND
DOPAMINE TRANSPORTERS
The purpose of Experiment 2 was threefold. The first
purpose was to examine the effects of early manganese
exposure on general motoric ability of neonatal and adult
rats. It was expected that neonatal manganese treatment
would cause impairments in neonatal sensory and motor
development, and impair balance and coordination in
adulthood. The second purpose was to investigate the
effects of neonatal manganese on basal and cocaine-induced
locomotor activity of preweanling and adult rats. It was
predicted that manganese-exposed rats would exhibit an
attenuated locomotor response to cocaine challenge. The
final purpose was to assess the effects of early manganese
exposure on dopamine transporter binding sites in the
striatum. It was expected that early manganese exposure
would decrease the number of striatal dopamine
transporters.
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Methods
Manganese Treatment
A total of 72 rats (n = 8 per group) were used in this
experiment. On PD 1-21, rats were given supplements
consisting of 0, 250, or 750 pg manganese dissolved in 25 pi
of 10% sucrose solution.
Apparatus
Locomotor activity was measured using commercially
available activity chambers (Coulbourn Instruments,
Allentown, PA). For neonatal and preweanling animals the
chambers measured 25.5 x 25.5 x 41 cm and for adult animals
the chambers measured 41 x 41 x 41 cm. Both sized chambers
consisted of acrylic walls, a plastic floor, and an open
top. Each chamber utilized an X-Y photobeam array with 16
photocells and detectors to determine the total distance
traveled (a measure of horizontal locomotor activity).
Olfactory orientation was measured in a Plexiglas
enclosed runway (12 x 28 x 12 cm) with soiled home bedding
at one end and clean bedding at the other end. Negative
geotaxis was tested on a 25° Plexiglas inclined plane. The 
surface of the inclined plane was covered with sandpaper.
Adult balance and coordination was evaluated on an elevated
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balance beam (49 x 22 x 150 cm) at a 15° incline. A darkened
goal box was placed at the elevated end of the beam. For
male rats the beam width was 1.9 cm and the beam width for
females was 1.3 cm.
Procedures
Developmental Landmarks. Pups were fed manganese daily
between PD 1-21 and evaluated daily for developmental
landmarks (i.e., eye opening, pina detachment, and incisor
eruption). Specifically, eye opening was recorded when both
eyes lids were completely separated. Pina detachment was
recorded when the tip of the ear is separated from the
head. Incisor eruption was recorded on the first appearance
of upper incisors. Body weights were recorded on alternate
days.
Neonatal Sensory and Motor Development. Negative
geotaxis was used to measure the development of motor
ability and motor reflex. On PD 8, PD 10, and PD 12
neonatal pups were placed head down on the 25° inclined 
plane and latency to rotate 180° on the inclined plane was
measured during a 120 s testing session. If the rat fell,
crawled off the plane, or braced (no movement), the rat
failed the task and a maximum time of 120 s was assigned.
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Olfactory discrimination was assessed as a measure of
sensory development. On PD 9, PD 11, and PD 13 all pups
were tested individually for olfactory discrimination of
their home cage bedding. Specifically, 5-day old soiled
bedding from their home cage was placed at one end of the
runway while fresh bedding was placed at the other end.
Each pup was placed on a center line with the head facing
the Plexiglas wall. Latency to reach the home bedding was
recorded. If the pup did not complete the trial in 120 s or
if the pup reached the clean bedding, the pup was
considered to have failed the task and a maximum time of
120 s was assigned.
Locomotor activity was used to as a measure of motor
development. On PD 10, PD 12, and PD 14 motor activity for
each pup was recorded for 1 min in the activity chambers.
Total distance traveled and total number of movements per
episode was recorded.
Adult Balance and Coordination. On PD 90, manganese-
exposed adult rats were tested for balance and coordination
using a balance beam task. Each rat was given three trials.
On trial 1, rats were placed in the goal box for 30 s. Then
an experimenter blind to the treatment condition placed the
rat on the low end of the balance beam. On trials 2 and 3,
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centrifuged at 20,000 x g at 4° C for 20 min. The pellet was
resuspended in ice-cold buffer and centrifuged again at
20,000 x g at 4° C for 20 min. The final pellet was
suspended in 12 vol of buffer. Protein concentrations for 
the final pellet were determined using the Bio-Rad Protein
Assay with BSA as the standard.
Saturation binding assays were conducted in duplicate.
Each assay tube contained 430 pg of buffer, varying levels 
of [3H]GBR 12935 (12 final concentrations, 0.1 - 37 nM), and 
tissue suspensions (50 pg/protein). Non-specific binding
was determined in the presence of 10 pg GBR 12909 which
selectively inhibits dopamine transporter function. The 
incubation period lasted 90 min at 4° C. Incubation was 
terminated by vacuum filtration (Brandell) over glass
filter fibers (Brandell) previously soaked in 0.1%
polyethylenimine. Filters were washed three times with ice-
cold Krebs-HEPES buffer and radioactivity was measured by
liquid scintillation spectrometry.
Statistics
Behavioral Data. Separate between subject (manganese
condition x sex) ANOVAs were used to analyze eye opening,
pina detachment, and incisor eruption. Body weights
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throughout the neonatal period were analyzed using 3 x 2 x
11 (manganese condition x sex x day) repeated measures
ANOVA. Negative geotaxis, olfactory orientation, and
neonatal locomotor activity were analyzed using 3x2x3
(manganese condition x sex x day) repeated measures ANOVAs.
To control for litter effects, means were calculated on
each dependant measure for manganese treatment groups (0,
250, or 750 pg manganese) for both male and female rat
pups. Thus, only one score was used for each level of
manganese pretreatment per litter per sex. On the balance
beam task, time to travel to the goal box, freezes and foot
slips were analyzed with separate 3x2x3 (manganese
condition x sex x trial) repeated measures ANOVAs.
For preweanling rats, saline and cocaine-induced
locomotor activity was analyzed using a3x3x2xl2
(manganese condition x cocaine dose x sex x time block)
repeated measures ANOVA. Pre-injection body weights were
analyzed using a 3 x 2 (manganese condition x sex) ANOVA.
For adult rats, locomotor activity was analyzed using a 3 x
3 x 2 x 12 x 5 (manganese condition x cocaine dose x sex x
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time block x days) ANOVA. All post hoc comparisons were done
using Tukey tests (p < .05).
Neurochemical Data. Dopamine transporter binding sites
(Bmax) and affinity (Fd) were determined using nonlinear
regression with Prism (GraphPad Software, San Diego, CA).
Bmax and Kd data from homogenate ligand-binding assays were
analyzed using separate randomized block (manganese
condition) between-subject ANOVAs. Each of the 7 assays
were treated as separate blocks. This statistical procedure
allows for the variance between assays to be partitioned
out of the error term. All post hoc comparisons were done
using Tukey tests (p < .05).
Results
Neonatal Assessments
Manganese exposure caused a significant reduction in
body weights [manganese main effect, F(2,90)=3.93, P <
0.05]. This effect was only evident during the later part
of the exposure phase, because rats exposed to 750 pg
manganese weighed less than rats exposed to vehicle or 250
pg manganese on PD 15-21 (Fig. 11) [manganese x day
interaction, F( 20,900)=1.88, P < 0.05]. Overall, male
pups (21.32 g ± .28) weighed more than female pups
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Postnatal Day
Figure 11. Mean (± S.E.M.) body weight data of preweanling 
rats (n = 31-33) treated from PD 1-21 with daily oral 
supplements of manganese (0, 250, or 750 pg). 
aSignificant difference between rats exposed to 250 pg or 
750 pg manganese (P < 0.05).
^Significant difference between rats exposed to vehicle 
or 750 pg manganese (P < 0.05).
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(20.60 g ± .26) regardless of manganese condition [sex
main effect, F(2,90) =4.15, P < 0.05].
Manganese exposure did not alter developmental
landmarks including: pina detachment, incisor
eruption, or eye opening (Table 1). Manganese exposure
did affect performance on the negative geotaxis task,
because rats exposed to manganese exhibited an
increased latency to turn 180° on a 25° inclined plane
(Table 2) [manganese main effect, F(2,44)=4.45, P <
0.05]. Performance on the olfactory discrimination
task and motor activity task was not affected by
manganese exposure (Table 3).
Acute Cocaine Challenge: Preweanling Rats
On PD 23, body weights did not vary according to
manganese treatment or sex (Table 4). Manganese exposure
did not alter basal or cocaine-induced locomotor activity
of preweanling rats (Fig. 12); however, rats challenged
with cocaine on PD 23 (10 and 20 mg/kg) showed enhanced
distance traveled scores when compared to vehicle-treated
rats (Fig. 12) [cocaine main effect, F(2,134)=159.25, P <
0.05]
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Table 1. Mean (± S.E.M.) Age (postnatal day, PD) at 
Expression of Developmental Landmarks.
Treatment Developmental Landmarks
Pina Incisor Eye
Detachment Eruption Opening
Vehicle 3.52 ± 0.16 9.30 + 0.22 15.60 ± 0.17
250 pg 3.60 ± 0.17 9.19 ± 0.11 15.58 ± 0.13
Manganese
750 pg 3.57 ± 0.16 9.25 ± 0.18 15.53 ± 0.10
Manganese
Note: Rats were exposed to vehicle or manganese on PD 1-21.
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Table 2. Mean (± S.E.M.) Latencies (s) of Rat Pups to 
Complete the Negative Geotaxis Task.
Treatment Negative Geotaxis
PD 8 PD 10 PD 12 Average
Vehicle 27.15 ± 6.78 16.90 ± 4.16 12.10 ± 1.55 18.72 ± 2.91
250 pg 
Manganese
19.16 ± 3.87 15.80 + 3.57 12.05 ± 2.45 15.67 ± 2.04
7 50 pg 
Manganese
28.86 ± 6.08 29.11 ± 8.10 22.53 ± 5.59 a26.83 ± 2.91
Note: Rats were exposed to vehicle or manganese on PD 1-21. 
aSignificantly different from rats exposed to vehicle or 250 
pg (P < 0.05).
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Table 3. Mean (± S.E.M.) Latencies (s) and Distance 
Traveled Scores (cm) of Rat Pups Tested on the Olfactory- 
Orientation and Motor Activity Tasks.
Treatment Sensory and Motor Development
Olfactory Orientation Motor Activity
Vehicle 34.32 ± 3.11 288.88 ± 5.13
250 pg Manganese 36.11 ± 3.12 283.97 ± 5.55
750 pg Manganese 33.78 ± 3.12 280.72 ± 6.99
Note: Rats were exposed to vehicle or manganese on PD 1-21. 
Olfactory orientation was measured on PD 9, 11, and 13, 
while distance traveled was measured on PD 10, 12, and 14.
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Table 4. Mean (± S.E.M.) Body Weights (g) of Male and 
Female Rats on PD 23 and 91.
Treatment 0 pg Mn 250 pg Mn 750 pg Mn
PD 23
Males 59.56 ±2.02 58.09 ±1.92 57.01 ±2.71
Females
57.94 ± 1.69 57.35 ±1.49 52.93 ±1.81
PD 91
Males 382.37 ± 4.64 a 390.45 ± 4.20 a 389.64 ± 3.99 a
Females 237.75 + 2.38 238.95 ±3.09 237.96 ±2.83
Note: Rats; were exposed to vehicle or manganese on PD 1-21.
aSignificantly different from female rats (P < 0.05).
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Figure 12. Mean (± S.E.M.) distance traveled scores of rats 
(n = 16-17) challenged with cocaine (10 or 20 mg/kg) or 
saline on PD 23. Rats were injected after a 5 min 
habituation period and immediately placed into the chamber 
where locomotor activity was assessed for 60 min. Rats had 
been exposed to vehicle or manganese (250, or 750 pg) on PD 
1-21.
aSignificantly different from rats given a challenge 
injection of 0 mg/kg cocaine (P < 0.05).
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Adult Balance and Coordination
When tested on the balance beam, latency to reach the
goal box did not differ in male rats exposed to vehicle
(48.48 s ± 9.42), 250 pg (47.70 s ± 10.75) or 750 pg (46.76
s ± 5.64) manganese. Similarly, female rats exposed to
vehicle (48.88 s ± 9.85), 250 pg (55.75 s ± 10.52) or 750
pg (60.58 s ± 10.68) manganese did not differ on the
balance beam.
Acute Cocaine Challenge: Adult Rats
On PD 91, body weights of vehicle- and manganese-
exposed rats did not differ, however male rats weighed
significantly more than female rats (Table 4) [sex main
effect, F(l,140)=2554.99, P < 0.05]. Distance traveled
scores of manganese-exposed rats did not interact with
cocaine and sex (Fig. 13) [manganese x cocaine x sex
interaction, F(2,128)=2.37, P = 0.056]; however, the
cocaine variable interacted with sex to affect behavior
[cocaine x sex interaction, F(2,128)=14.81, P < 0.05]. More
specifically, an acute challenge injection of cocaine
caused a dose-dependant increase in the distance
traveledscores of male and female rats, with both doses of
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5-Min Time Blocks 5-Min Time Blocks
Figure 13. Mean (± S.E.M.) distance traveled scores of rats 
(n = 8-9) challenged with cocaine (0, 10 or 20 mg/kg) on PD 
91. Rats were injected after a 5 min habituation period and 
immediately placed into the chamber where locomotor 
activity was assessed for 60 min. Rats had been exposed to 
manganese (250 or 750 jig) or vehicle on PD 1-21.
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cocaine causing significantly greater distance
traveled scores in female rats than male rats (Fig.
14) .
Cocaine also interacted with the manganese
variable to affect distance traveled scores [cocaine x
manganese interaction, F(4,128)=3.59, P < 0.05]. When
challenged with saline, distance traveled scores of
vehicle- and manganese-exposed rats did not differ
(Fig. 15, upper graph). In contrast, when challenged
with 10 mg/kg cocaine, rats previously exposed to 250
pg manganese had smaller distance traveled scores than
vehicle controls during time blocks 2 and 3 (Fig 15,
middle graph) [manganese x time block interaction,
F( 14,322)=2.30, P < 0.05]. When challenged with 20
mg/kg cocaine, rats exposed to 750 pg manganese had
smaller distance traveled scores than rats exposed to
vehicle or 250 pg manganese [manganese main effect,
F(2, 43)=3.44, P < 0.05] (Fig 15, lower graph).
Additionally, cocaine caused a dose-dependent increase
in the distance traveled scores of rats exposed to
vehicle or 250 pg manganese, but not for rats exposed
to 750 pg manganese (Fig. 16).
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Adult Rats
Cocaine (mg/kg)
Figure 14. Mean (± S.E.M) distance traveled scores of rats 
(n = 24-25) challenged with cocaine (0, 10 or 20 mg/kg) or 
saline on PD 91. Rats were injected after a 5 min
habituation period and immediately placed into the chamber 
where locomotor activity was assessed for 60 min. Rats had 
been given daily oral supplements of manganese (250 or 750 
pg) or vehicle on PD 1-21.
aSignificantly different from same-sexed rats given a 
challenge injection of 0 mg/kg cocaine (P < 0.05). 
bSignificantly different from male rats given the identical 
dose of cocaine (P < 0.05).
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Figure 15. Mean (± S.E.M) distance traveled scores of male 
and female rats (n = 16-17) challenged with cocaine (0, 10, 
or 20 mg/kg) on PD 91. Rats were injected after a 5 min 
habituation period and immediately placed into the chamber 
where locomotor activity was assessed for 60 min. Rats had 
been exposed to manganese (250 or 750 pg) or vehicle on PD 
1-21.
aSignificantly different from rats pretreated with 0 pg 
manganese and challenged with the identical dose of 
cocaine (P < 0.05).
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Figure 16. Meanj (± S.E.M) distance traveled scores of rats 
(n = 16-17) challenged with cocaine (0, 10 or 20 mg/kg) on 
PD 91. Rats were injected after a 5 min habituation period 
and immediately|placed into the chamber where locomotor 
activity was assessed for 60 min. Rats had been exposed to
manganese (250 or 750 pg) or vehicle on PD 1-21.
aSignificantly different from rats exposed to the same dose 
of manganese ana given a challenge injection of 0 mg/kg 
cocaine (B < 0.p5).
bSignificantly different from rats exposed to the same dose 
of manganese and given a challenge injection of 10 mg/kg 
cocaine (B < 0.05).
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Dopamine Transporter Binding Sites
Neonatal manganese exposure caused a decrease in
!i
striatal dopamine transporter binding sites that persisted
into adulthood [manganese main effect, F(2, 16)=3.72, P < 
0.05] (Fig. 17).j Specifically, rats exposed to 750 pg 
manganese had smaller B^x values than control rats (Fig.
18). Manganese did not significantly affect Ka values,
although there was a trend for manganese to cause a dose-
dependant decline in Fd (Table 5) .
Discussion: Experiment Two 
Evidence fiom other studies has suggested that
exposure to manganese can result in behavioral and
II
neurological changes to the developing nervous system.
However, it is not clear if chronic exposure to low or
moderate doses of manganese during the neonatal period is
capable of inducing long-term changes in behavior. Thus,
one purpose of this experiment was to assess the effects of
manganese on standard measures of physical, sensory, and
motor development during the neonatal period and then to
Iassess balance and coordination in adulthood. Exposure to 
environmental tjoxins can alter behavioral responses to 
dopaminergic drugs. Therefore, another purpose of this
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Figure 17. Representative [3H]GBR 12935 saturation curve of 
dopamine transporter binding in the striatum of male rats 
exposed to manganese (250 or 750 pg) or vehicle from PD 1- 
21.
i
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Figure 18. Mean (± S.E.M.) Bmax values for [JH]GBR 12935 
binding in the striatum of rats (n = 5-7) exposed to 
manganese (250 or 750 pg) or vehicle on PD 1-21. 
aSignificantly different from rats exposed to vehicle (P < 
0.05). i
i
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Table 5. Mean (± S.E.M.) Bmax and Kd Values for [JH]GBR 12935
Binding in the S-triatum of Rats Exposed to Manganese (250 
or 750 pg) or Vehicle on PD 1-21.
Bmax (fmol/mg protein) ■d (nM)
Vehicle
250 pg Manganese 
750 pg Manganese
932.15 ± 185.47 44.07 + 12.47
743.37 ± 105.74 31.78 + 7.70
355.92 + 100.86a 16.34 + 7.01
aSignificantly d 
0.05) .
ifferent from rats exposed to vehicle (P <
i
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experiment was to determine if early manganese exposure was 
capable of alterjing dopamine-mediated locomotor activity in 
preweanling and {adult rats. We found that manganese did not 
affect the expression of developmental landmarks, but did
reduce the norma 1 pattern of weight gain during the last
week of manganes'e exposure. Manganese (750 pg) also
impacted the development of motor coordination (i.e.,
negative geotaxi s) at PD 8 - 12 without concomitant effects
on olfactory ori'entation or motor activity. Additionally,
when tested on PD 23, basal and cocaine-induced motor
activity was not affected by manganese.
On PD 91, neonatal manganese exposure did not affect
basal motor activity of adult rats. However, when injected
with cocaine, manganese-exposed rats had smaller distance 
traveled scores 'than controls. Additionally, cocaine caused 
a dose-dependent increase in the locomotor activity of both 
male and female jrats, with female rats exhibiting more 
robust cocaine-induced locomotor activity than male rats.
In control rats,| manganese also reduced the density of
dopamine transporters in the striatum (Bmax) > while causing
a non-significant decline in affinity (Fd) .
Although exlposing mice to manganese during late
gestation has been reported to cause a delay in the
130
appearance of developmental landmarks (e.g., pina
detachment, incisor eruption, eye opening) (Torrente et
al., 2002), such changes were not evident in the current
study. The most obvious explanation is the method of 
manganese exposure, because during gestation the fetus is 
directly exposed to manganese crossing the placenta via
active transport (Krachler, Rossipal, & Micetic-Turk,
1999). Although fetal rats are more susceptible to the
neurotoxic effects of manganese than are neonatal and
preweanling rats, the current study demonstrates that
neonatal manganese exposure is capable of causing short­
term changes in the dopamine system that are apparent
during the preweanling period. Manganese delayed the
ability of rat pups (PD 8, 10, and 12) to coordinate the 
movements required to turn 180° on a 25° inclined plane. 
Proper execution of this task typically reaches asymptotic
levels by PD 8 and is dependant upon the vestibular system
(Adams et al., 1985). Dopamine is involved in modulating
the vestibular system either by directly stimulating
vestibular neurons or by modulating GABAergic neurons in
this area (Vibert, Serafin, Crambes, Vidal, & Muhlethaler,
1995). Manganese-induced changes in balance and
coordination were restricted to the preweanling period,
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because vehicle- and manganese-exposed adult rats performed
similarly on the balance beam task. In addition to
measuring negative geotaxis, vehicle- and manganese-exposed
rats were tested on olfactory discrimination and motor
movement tasks. Manganese did not affect performance on
either of these tasks. This pattern of results was
surprising, because both olfactory orientation and motor
movement are typically affected by manipulations of the
dopamine system (Adams et al., 1985; Tran, Chowanadisai,
Lonnerdal, Parker, Chicz-DeMet, & Crinella, 2002; Vorhees
et al., 1995).
Consistent with prior research, the high dose of
manganese decreased weight gain during the neonatal period
(Dorman et al., 2000; Pappas et al., 1996). This effect
dissipated with the cessation of manganese treatment,
because body weights of vehicle- and manganese-exposed rats
were similar on PD 23 and PD 91. Feeding behavior during
neonatal development is sensitive to manipulations of the
dopamine system, with both increased and decreased
dopaminergic transmission inducing anorexia (Raskin &
Campell, 1981; Zhou & Palmiter, 1995). The anorexia
evidenced by rat pups in the current study is suggestive of
an increase in dopamine transmission because a high dose of
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manganese increases both striatal dopamine and DOPAC levels
(Dorman et al., 2000). Of course, it remains possible that
the manganese-induced weight loss was mediated by non-
dopaminergic mechanisms.
Basal motor activity was not affected by neonatal
manganese exposure on PD 23 or PD 91. When challenged with
cocaine on PD 23, neither manganese treatment nor sex
impacted cocaine-induced behavior. However, when challenged
with 10 or 20 mg/kg cocaine on PD 91, male and female
manganese-exposed rats demonstrated a difference in the
response magnitude to cocaine. In particular, female rats
had greater distance traveled scores than male rats after
being treated with either dose of cocaine. In fact, female
rats treated with 10 mg/kg cocaine had distance traveled
scores that were similar to male rats treated with 20 mg/kg
cocaine. These data are consistent with previous reports
demonstrating that the efficacy of cocaine differs between
male and female rats. In particular, male rats require an
increased amount of cocaine to achieve the behavioral
intensity of female rats (Festa et al., 2004).
Overall, early manganese exposure caused an atypical
response pattern to the locomotor activating effects of
cocaine in adulthood. Specifically, manganese was
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responsible for a pronounced reduction in the behavioral
response to cocaine. Similar findings have been reported in
rats exposed to manganese from gestation to PD 80 and then
challenged with amphetamine (Leung et al., 1982). Several
explanations for these manganese-induced effects exist,
including 1) functional changes in postsynaptic receptors,
2) adaptive changes in the dopamine transporter, and 3)
biphasic alterations in neurotransmitter levels.
The marked reduction in distance traveled scores of
manganese-exposed rats suggests that manganese causes long­
term changes in the sensitivity of dopamine receptors. This
line of reasoning is primarily supported by studies
examining the effects of direct dopaminergic drugs on
postsynaptic terminals. In particular, manganese decreases
the frequency and amplitude of quinpirole-induced
excitatory postsynaptic potentials, suggesting a decreased
efficacy or decreased sensitivity of D2-like receptors
(Calabrassi et al., 2000). Additionally, manganese may
alter the functioning of Di-like dopamine receptors. The
attenuated motor activity observed in the present study
could be due to a dysfunction of the Di-like receptor,
because manganese decreases ligand binding to postsynaptic
Di-like receptors (Eriksson, Gillberg, Aquilonius, Hedstrom,
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& Heilbronn, 1992). In the current study, rats exposed to
750 pg manganese did not show the traditional dose-
dependant increase in cocaine-induced locomotor activity 
that was apparent in control rats. In particular, 20 mg/kg
cocaine did not increase locomotor activity beyond that of
the 10 mg/kg cocaine group. It is possible that a
manganese-induced dysfunction of the Di-like receptor may
interfere with the enabling role that Di-like receptors play
in D2~like mediated behaviors. Specifically, it is possible
that a manganese-induced subsensitivity of D2-like
receptors, in combination with dysfunctional Di-like
receptors, may hamper the synergistic coupling of Di-like
and D2-like receptors during development.
A more parsimonious explanation for the attenuated
response to cocaine is that manganese caused neurotoxicity.
This hypothesis is supported by the finding that dopamine
transporter binding sites were reduced in rats exposed to
manganese (750 pg) from PD 1 - 21. Loss of dopamine
reuptake sites is indicative of damage to dopamine
terminals (Frost & Cadet, 2000, Wagner, Ricaurte, Johanson,
Schuster, & Seiden, 1980). Most commonly, reductions in
dopamine transporters are associated with high doses of
psychostimulant drugs. A variety of environmental toxins,
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including manganese, are also transported into the
intracellular environment via dopamine transporters, thus
leaving the neuron vulnerable to toxicity (Bridges &
Zalups, 2005; Erikson, Byron, & Beard, 2000; Ingersoll,
Montgomery, & Aposhian, 1999; Miller et al., 1999).
Alternatively, reductions in the number of dopamine
transporter binding sites may reflect functional changes,
including declined affinity. Conformational changes (i.e.,
structural changes) decrease the affinity of dopamine
transporters to cocaine and similar reuptake blockers
depending upon the affected transmembrane domain (Goldberg,
Beuming, Soyer, Goldstein, Weinstein, & Javitch, 2003;
Loland, Granas, Javitch, & Gether, 2004; Loland, Norgaard-
Nielsen, & Gether, 2003). For example, changes in structure
can alter the distribution of conformational states as well
as interfering with the "gating" mechanism between the
inter- and extracellular environment (Goldberg, Beuming,
Soyer, Goldstein, Weinstein, & Javitch, 2003). In regards
to the present experiment, manganese-exposed rats showed a
trend towards decreased affinity. Since manganese exposure
occurred during a sensitive period (i.e., PD 1 - 21) for
the development of dopamine transporters (Galineau et al.,
2004; Tarazi, Tomasini, & Baldessaarini, 1998) it is
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possible that the decline in affinity may result from
manganese-induced changes in the conformation of the
dopamine transporter. This possibility is unlikely,
however, because manganese has been shown to cause
neurotoxicity with prolonged exposure, while not
interfering with 3H-dopamine uptake in the striatum 
(Defazio, Soleo, Zefferino, & Livrea, 1996) The latter 
finding is important because 3H-dopamine uptake is a direct 
indicator of the functionality of dopamine transporters.
In the current study, the pattern of behavioral
results is consistent with the biphasic progression of
manganese toxicity reported in neurochemical studies.
During the early stages of manganese poisoning, increases
in dopamine transmission have been reported (Dorman et al.,
2000; Seth & Chandra, 1984). In neonatal rats, manganese 
exposure decreased [3H]-spiroperidol binding (Seth & 
Chandra, 1984), which is consistent with reports of
manganese-induced increases in dopamine levels during the
neonatal period (Dorman et al., 2000; Seth & Chandra,
1984). As manganese toxicity progresses, damage to the
nigrostriatal pathway and the globus pallidus causes
behavioral abnormalities characteristic of manganese
poisoning. A dosing regimen of manganese, similar to the
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levels of manganese used in the current study, caused a
reduction in striatal dopamine levels at PD 40 and 62
(Tran, Chowanadisai, Crinella, Chicz-DeMet, & Lonnerdal,
2002; Tran, Chowanadisai, Lonnerdal, Le, Parker, Chicz-
DeMet, & Crinella, 2002). Thus, the manganese regimen used
in the present study is sufficient to cause long-term
depletions of striatal dopamine levels and a reduction in
dopamine transporter binding sites. When the present data
are combined together (i.e., the decreased body weights
during the neonatal period along with the pronounced
reduction in cocaine-induced behaviors on PD 91), it
appears that exposing rats to 750 pg manganese on PD 1 - 21
is sufficient to induce the biphasic alterations in
dopamine transmission that are commonly associated with
manganese toxicity (Aschner, 2000; Chandra & Shulka, 1981;
Mergler, 1999).
In summary, the results of Experiment 2 are
consistent with previous studies showing that exposure to
manganese during the preweanling period causes lasting
alterations in cocaine-induced behaviors. In addition,
weight gain and coordination were transiently affected by
manganese exposure. The behavioral changes observed in the
current experiment support the biphasic symptology
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evidenced during manganese toxicity. The behavioral effects
of manganese toxicity could be attributed to loss of
dopamine neurons, evidenced by decreased dopamine
transporters. Importantly, the levels of manganese used in
the current study are capable of causing long-term damage
to these membrane proteins, which may account for the
decreased locomotor activating effects of cocaine in
adulthood.
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CHAPTER TWELVE
EXPERIMENT THREE: THE EFFECTS OF NEONATAL
MANGANESE EXPOSURE ON COCAINE-INDUCED
CONDITIONED PLACE PREFERENCE
Methods
The purpose of Experiment 3 was to investigate the
effects of neonatal manganese treatment on drug reward by
utilizing a CPP paradigm. It was hypothesized that neonatal
manganese exposure would reduce the rewarding properties of
cocaine, as evidenced by a decreased amount of time spent
in the drug-paired compartment.
Manganese Treatment
A total of 72 rats (n = 8 per group) were used in this
experiment. On PD 1-21, rats were given daily supplements
consisting of 0, 250, or 750 pg manganese dissolved in 25 pi
of 10% sucrose solution.
Apparatus
Conditioned place preference was assessed in a T-
shaped plywood chamber that had three compartments
separated by removable partitions. The two end compartments
measured 24 x 30 x 45 cm high, while the offset compartment
measured 24 x 10 x 45 cm high. One end compartment had white
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walls, a wire mesh floor, and pine bedding beneath the
floor. The other end compartment had black walls, a metal
bar floor, and cedar bedding beneath the floor. The offset
compartment had gray walls and a solid wood floor. The
solid partitions could be replaced with partitions
containing 10 x 10 cm openings, which allowed rats free
access to the two end compartments.
Procedures
Following acclimation to handling, 90-day-old rats
from the three manganese conditions were placed in the
offset compartment (the start box) and allowed free access
to the two end compartments for 900 s. Initial compartment
preference was recorded.
On day 1 of conditioning, half of the rats were
restricted to the black compartment and half restricted to
the white compartment for 1800 s. Rats placed in the white
compartment were injected with cocaine (0, 10, or 20 mg/kg,
i.p.), whereas rats placed in the black compartment were
injected with saline. On day 2 of conditioning, rats were
restricted to the opposite compartment for 1800 s. Rats
previously injected with cocaine were given an injection of
saline, whereas rats previously given saline were injected
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with either 0, 10 or 20 mg/kg cocaine. Conditioning lasted
a total of 8 days with alternating daily placements in the
black and white compartments.
On the test day (i.e., day 9), rats were placed in the
offset compartment and allowed free access to the entire
apparatus for 900 s. Time spent in each chamber were
recorded.
Statistics
Separate between-subject 3x3x2 ANOVAs (manganese
condition x drug dose x sex) were used to analyze place
preference data. Initial preference day, acquisition test
day data, extinction test day data, and reinstatement data
were analyzed separetly. Post hoc comparisons were done
using Tukey tests (p < .05).
Results
Body Weights
Overall, manganese exposure caused a reduction in the
body weights of rat pups [manganese main effect,
F(2,62)=3.67, P < 0.05]. This effect was evident during the
later part of the manganese treatment phase, because rats
pretreated with 750 pg manganese weighed less than rats
pretreated with vehicle or 250 pg manganese on PD 13 - 21
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(Fig. 19) [manganese x day interaction, F( 20, 620)=1.94, P <
0.05]. When measured on PD 91, body weights of adult rats
were not affected by neonatal manganese exposure. Not
surprisingly, adult male rats (384.40 g ± 4.25) weighed 
significantly more than adult female rats (239.4 g ± 2.79)
[sex main effect, F(l,99)=844.36, P < 0.05].
Conditioned Place Preference: Conditioning,
Extinction and Reinstatement
Prior to conditioning, a preference for the black side
of the apparatus was apparent. This preference did not
differ according to manganese exposure or sex (Fig. 20). In 
control animals, the black preference persisted throughout
acquisition, extinction and reinstatement.
On the conditioning test day, rats that received
cocaine showed a robust preference for the white (drug- 
paired) compartment (Fig. 21, upper right graph). 
Specifically, conditioning with 10 or 20 mg/kg cocaine
caused an increase in time spent on the drug-paired side
relative to saline controls [cocaine main effect,
F(2,83)=45.84, P < 0.05]. The place preference for cocaine
disappeared by the extinction test day, because rats 
conditioned with cocaine or saline spent similar amounts of
time in the white (drug-paired) compartment (Fig. 21, lower
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Figure 19. Mean (± S.E.M.) body weights of preweanling rats 
(n = 22-24) treated from PD 1-21 with daily oral 
supplements of manganese (250 or 750 pg) or vehicle. 
aSignificant difference between rats treated with vehicle 
and 750 pg manganese (P < 0.05).
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Figure 20. Mean (± S.E.M.) time (s) spent in the white 
compartment on the initial preference day (PD 90) for male 
and female rats (n = 13-16) previously exposed to manganese 
(250 or 750 pg) or vehicle from PD 1-21.
Females
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Figure 21. Mean time spent (± S.E.M.) in the drug-paired 
compartment on the Pre-Conditioning day, Conditioning, 
Extinction, and Reinstatement test days. Rats (n = 27-33) 
were initially given four alternating daily injections of 
cocaine (10 or 20 mg/kg) or vehicle prior to placement on 
the white side and four alternating injections of saline 
prior to placement on the black side. During eight days of 
extinction training, rats were injected with saline and 
given alternating daily placement in the black and white 
compartments. On the Reinstatement test day all rats were 
primed with 20 mg/kg cocaine immediately prior to the 
testing session. Rats were previously exposed to manganese 
(250 or 750 pg) or vehicle from PD 1-21.
aIndicates a significant difference from rats conditioned 
with saline (P < 0.05).
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left graph). The cocaine-induced preference was reinstated
on the final test day. Overall, a priming dose of cocaine
reinstated a place preference in those rats originally
conditioned with either 10 or 20 mg/kg cocaine (Fig. 21,
lower right graph) [cocaine main effect, F(2,82)=18.7, P
<0.05].
There was no evidence that manganese caused any
alterations in the acguisition, extinction, or
reinstatement of cocaine CPP (Fig. 22). Likewise, sex did
not interact with manganese or cocaine to influence CPP.
Discussion: Experiment Three
Manganese accumulates in areas of the brain (e.g.,
nucleus accumbens, prefrontal cortex, and globus pallidus)
associated with the rewarding properties of psychostimulant
drugs (Berridge, 2003; Fell et al., 1996; Gong, Neill, &
Justice, 1996; 1997; Komaki et al., 1999; McBride et al.,
1999; Panagis et al., 1997). However, it was unknown
whether exposure to manganese during neonatal development
would cause lasting changes in drug reward. For this
reason, the acquisition, extinction, and reinstatement of
cocaine-induced CPP was examined in male and female rats
exposed to manganese, from PD 1-21. Consistent with data
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Figure 22. Mean time spent (± S.E.M.) in the drug-paired 
compartment on the Conditioning, Extinction, and 
Reinstatement test days. Rats (n = 9-12) were exposed to 
manganese (250 or 750 pg) or vehicle from PD 1-21 and 
conditioned with cocaine (0, 10, or 20 mg/kg) on four 
alternating days. The place preference was extinguished 
across eight daily sessions, and reinstated with a priming 
dose of 20 mg/kg cocaine.
a Indicates a significant difference from rats conditioned 
with saline (P < 0.05).
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from our laboratory (see Experiment. 2) and others (Dorman
et al., 2000; Pappas et al., 1996), rat pups treated with
750 pg manganese had reduced body weights during the later
part of manganese treatment (PD 13-21). As expected, these
initial differences in body weight were not apparent prior
to the beginning of CPP conditioning (i.e., PD 90).
Originally, it was hypothesized that manganese exposure
would decrease the rewarding properties of cocaine. Male
and female rats in this study showed a robust preference
for the cocaine-paired side after the conditioning period,
and this preference was successfully extinguished and
reinstated with subsequent testing. However, there was no
indication that manganese treatment interfered with the
acquisition, extinction or reinstatement of cocaine CPP.
Male and female rats exhibited similar patterns of
responding through-out CPP acquisition, extinction and
reinstatement. Recently, it has been demonstrated that
gonadal hormones have a role in modulating the rewarding
effects of cocaine, thus causing an increased sensitivity
to the drug in female rats (Russo, Festa, Fabian, Gazi,
Kraish, Jenab, & Quinones-Jenab, 2003). However, this
effect primarily results from female rats, when compared to
male rats, showing place conditioning to lower amounts of
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the drug after fewer cocaine pairings (Russo et al., 2003). 
It has been reported that 10 mg/kg cocaine reliably induces 
place preferences in both male and female rats, while 20 
mg/kg cocaine may be the preferential dose for male rats 
(Russo et al., 2003). In the present study, 20 mg/kg
cocaine produced robust CPP in both male and female rats.
Russo et al. (2003) used a four-day conditioning period
whereas we used an eight-day conditioning procedure,
perhaps indicating that sex differences associated with
cocaine-induced CPP are dependant on fewer conditioning
sessions.
The current study shows that the CPP responding of
female rats, like male rats, can be extinguished and
reinstated with a priming dose of cocaine. This finding
indicates that male and female rats are capable of forming
associations between contextual stimuli and the rewarding
effects of cocaine, and that the salience of these
contextual cues can be extinguished and subsequently
reinstated with a priming injection of cocaine (Mueller &
Stewart, 2000). These results are not consistent with
cocaine self-administration studies, which demonstrated
that female rats respond more robustly to a priming
injection of cocaine than male rats (Lynch & Carroll,
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2000). In self-administration studies, however, rats are
required to engage in an operant response to obtain the
drug, while the CPP procedure relies on Pavlovian
associations formed between contextual stimuli and the
rewarding effects of the drug (i.e., an operant response is
not required). Moreover, in the former situation delivery
of the drug is controlled by the animal, whereas in the
latter situation drug administration is controlled by the
experimenter. Differences between drug-self administration
and CPP tasks may mean that separate neuronal mechanisms
underlie the reward processes associated with the two
behavioral paradigms (Bardo & Bevins, 2000). Therefore,
sex-differences observed in the reinstatement of cocaine
self-administration may be attributed to differences in the
reinforcing effects of cocaine; whereas, the similar
reinstatement patterns of male and female rats in a CPP
paradigm may indicate a lack of sex differences in those
mechanisms responsible for forming the association between
contextual stimuli and the rewarding properties of cocaine.
It is not known whether sex differences in the
reinstatement of cocaine CPP would emerge if a less optimal
CPP paradigm were used (i.e., fewer sessions or lower doses
of cocaine).
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Given recent reports demonstrating that environmental
neurotoxins can interfere with reward function (Guillot,
Richardson, & Miller, 2004), it is surprising that
manganese exposure did not impact the acquisition,
extinction, or reinstatement of cocaine-induced CPP. The
most likely explanation is that manganese differentially
affects the nigrostriatal and mesolimbic dopamine systems.
Although manganese accumulates in brain areas that make up
the mesolimbic dopamine system, manganese preferentially
damages dopamine neurons in the nigrostriatal pathway
(Eriksson, Lenngren, & Heilbronn, 1987; Erikson, Shihabi,
Aschner, & Aschner, 2002; Fell et al., 1996; Komaki et al.,
1999). Thus, the nigrostriatal system is more susceptible
to manganese toxicity than the mesolimbic reward system.
Alternatively, the dosing paradigm used in this experiment
may not have been sufficient to alter the mesolimbic
dopamine system. Behavioral manifestations of manganese
toxicity are dependant on age of exposure and testing,
route and dose of administration, and the biphasic
progression of toxicity (see Chapter 5). Therefore, it is
unknown if a more aggressive manganese exposure paradigm
would interfere with reward system functioning.
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In conclusion, the findings of this experiment show
that neonatal manganese exposure did not impact the
acquisition, extinction, or reinstatement of cocaine CPP.
However, manganese exposure from PD 1-21 did cause a
transient decrease in body weights during the neonatal
period. In addition, this experiment showed that place
preference to cocaine can be extinguished and later
reinstated in response to a priming dose of cocaine in
female rats as well as male rats. Experiment 3 also
demonstrated that sex differences are not observed when
cocaine-induced CPP is measured after an eight day
conditioning period (four cocaine pairings and four saline
pairings).
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CHAPTER THIRTEEN
GENERAL DISCUSSION
Manganese is a complex trace mineral that is an
essential nutrient but, at high levels, may also be a
neurotoxicant. It is generally believed that children and
infants may be at a particular risk for manganese
neurotoxicity due to an immature central nervous system
(Cawte, 1985; Mergler, 1999; Takada et al., 1999; Weiss,
1999). Importantly, infant formulas contain substantially
more manganese than the recommended daily allowance, so
this sub-population of infants may be at particular risk
for developing lasting brain changes that result in long­
term behavioral dysfunction (Lonnerdal, 1994). There is
even evidence that the amount of manganese contained in
soy-based infant formula may be sufficient to induce brain 
changes responsible for ADHD (Tran, Chowanadisai, Crinella,
Chicz-DeMet, & Lonnerdal, 2002; Tran, Chowanadisai,
Lonnerdal, Le, Parker, Chicz-DeMet, & Crinella, 2002) .
Therefore, the purpose of this thesis was to examine the
effects of low to moderate doses of manganese (0, 250, or 
750 pg per day from PD 1-21) on a comprehensive battery of 
behaviors that are sensitive to disruption of the dopamine
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system. The three experiments comprising this thesis
evaluated behavior during the neonatal period, preweanling
period, and adulthood.
Manganese exposure did not affect the appearance of
developmental landmarks, nor did it alter neonatal motor
activity or olfactory orientation. Manganese did, however,
impair neonatal motor coordination and depressed body
weight gain on PD 13-21. After cessation of manganese
treatment on PD 21, body weights returned to control levels
by PD 23. Importantly, manganese exposure did not affect
basal or cocaine-induced locomotor activity on PD 23. When
tested at PD 90, however, manganese-exposed rats exhibited
both reduced responding on a DRL 20 task and a pronounced
reduction in cocaine-induced motor activity. Early
manganes| exposure did not affect basal motor activity,
balance, or coordination at PD 90. Additionally, manganese
did not alter the rewarding properties of cocaine, as
measured by the acquisition, extinction, and reinstatement
of CPP.
When considered together, the present results suggest
that early manganese exposure causes a long-term
suppression in the initiation of motor movement, without
altering reward or learning processes. Manganese-induced
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reductions in bar press responsivity are not likely due to
a learning impairment, because manganese did not interfere
with acquisition of either a response contingent behavioral
task (Experiment 1) or CPP (Experiment 3). These learning
paradigms differ because the former task requires the
performance of an overt voluntary behavior, while the later
task relies on the pairing of two previously unrelated
stimuli. Since manganese-induced deficits impacted the
execution of rapidly occurring bar press responses, and not
the learning of response contingencies, it is likely that
the behavioral differences were due to motor impairment.
Moreover, the inability of manganese to alter the
acquisition, extinction, and reinstatement of cocaine-
induced CPP further suggests that learning mechanisms are
not affected by neonatal manganese exposure. However, it is
possible that manganese may cause learning impairments that
are not sensitive to the DRL or CPP paradigms.
The pronounced decrease in cocaine-induced locomotor
activity observed in manganese-exposed rats (Experiment 2)
is also consistent with a motor impairment hypothesis
rather than a reward hypothesis. This conclusion is
supported by the finding that early manganese exposure did
no't impact the acquisition, extinction, or reinstatement of
156
cocaine CPP in adulthood (Experiment 3). Cocaine-induced
locomotor activity and CPP are mediated, at least
partially, by the mesocorticolimbic dopamine system (Bardo,
1998; Dickson, Lang, Hinton, & Kelly, 1994; Mele, Thomas, &
Pert, 1998; Wise & Bozarth, 1987). Motor movement, on the
other hand, is primarily mediated by the nigrostriatal
dopamine system, because damage to this system impairs
various indices of motoric function in both humans and
animals (Arnt, 1987; Caine et al., 1994; Carey, 1986;
Goldberg et al., 2003; Olanow et al., 1996). Importantly, 
chronic manganese exposure causes cell loss in the
nigrostriatal pathway, which is characterized by
bradykinesia, dystonia, and widespread muscular rigidity
(Aschner, 2000; Caine et al., 1994; Mergler, 1999).
Therefore, the most parsimonious conclusion is that early
manganese exposure causes motoric deficits that result from
dysfunction of the nigrostriatal dopaminergic system. In
particular, manganese-induced reductions in striatal
dopamine transporters is suggestive of neurotoxicity.
Motoric deficits are evidenced by decreased bar press
responding on a DRL schedule of reinforcement and
attenuation of psychostimulant-induced locomotor activity.
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Motor impairments observed in ADHD children involve 
dopaminergic transmission in the nigrostriatal pathway 
(Johansen et al., 2002; Sagvolden et al., 1998). However,
manganese-induced motor impairments evidenced in this study
are not consistent with established rodent models of ADHD
(i.e., 6-OHDA lesions, spontaneously hypertensive rats, and
PCB-exposed rats) (for a review, see Davids, Zhang, Tarazi,
& Baldessarini, 2003) . For example, in one rodent model of
ADHD, 6-hydroxydopamine (6-OHDA) lesions are used to reduce
dopamine transporter binding in the striatum and nucleus
accumbens (Davids, Zhang, Tarazi, & Baldessarini, 2002).
These 6-OHDA-treated rats exhibit robust increases in basal
motor activity, that return to control levels with
methylphenidate treatment (Davids et al., 2002). A second
rodent model of ADHD utilizes spontaneously hypertensive
rats. These rats display hyperactive behaviors consistent
with ADHD, show decreased dopamine and serotonin turnover
in the striatum, and respond more quickly than controls to
an acute challenge of methylphenidate (Amini, Yang, Swann,
& Dafny, 2004; de Villiers, Russell, Sagvolden, Searson, 
Jaffer, & Taljaard, 1995; Russell, de Villiers, Sagvolden,
Lamm, & Taljaard, 2000). A third rodent model involves 
exposing neonatal rats to PCBs. These rats show increased
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hyperactivity when compared to controls (Holene, Nafstad,
Skaare, & Sagvolden, 1998). In the present study,
manganese-exposed rats did not exhibit behaviors consistent
with established rodent models of ADHD. Specifically, the
basal locomotor activity of manganese- and vehicle-exposed
rats was similar and manganese-treated rats showed a
lessened responsivity to cocaine. Manganese-exposed rats
also exhibited reduced bar pressing, bin 1 responses, and
burst responses. In contrast, both spontaneously
hypertensive rats and PCB-exposed rats exhibit an increase
in burst responses, which is suggestive of the impulsivity
associated with ADHD (Biox, Qiao, Kolpus, & Sagvolden,
1998; Holene et al., 1998). In summary, manganese-exposed
rats do not respond in a manner similar to the established
rodent models of ADHD.
Dysregulation of the dopamine system causes ADHD-type
symptomology. The dopamine transporter has been implicated
as a source of dysregulation by both genetic studies (Barr
et al., 2001; Cook et al., 1995; Gill, Daly, Heron, Hawi, &
Fitzgerald, 1997; Waldman et al., 1998) and neuroimaging
studies (Cheon et al., 2003; Jucaite, Fernell, Halidin,
Forssberg, & Farde, 2005; Krause, Dresel, Krause, la
Fougere, & Ackenheil, 2003). Generally, neuroimaging
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studies show increased striatal dopamine transporters in
ADHD patients (Krause et al., 2003; Cheon et al., 2003).
The expression of more dopamine transporters suggests 
increased dopamine reuptake in ADHD cases. The result is a
decrease of extracellular dopamine concentrations that is
consistent with the dopamine hypothesis of ADHD (Swanson et
al., 2000). In rodent models, spontaneously hypertensive
rats also show an increase in striatal dopamine
transporters (Watanabe et al., 1997). These findings are in
distinct contrast with the present study, in which I found
that early manganese exposure causes a persistent reduction 
of dopamine transporters. Taken together, these findings
are consistent with the idea that neonatal manganese
exposure produces neurotoxicity that is unrelated to the
development of ADHD-type behaviors.
Although the results from this thesis suggest that
neonatal manganese exposure does not induce ADHD-type
symptoms, manganese does appear to have long-term
behavioral and neuronal consequences that are not expressed
until adulthood. Exposure to other neurotoxic substances
can also have long latency periods resulting in "silent"
damage (Weiss, Clarkson, & Simon, 2002). This is important
because pre-exposure to neurotoxicants may exacerbate or
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cause the early expression of neurodegenerative disorders
(i.e., Parkinson's Disease) that result from age-related
cell loss (Caine, Eisen, McGeer, & Spencer, 1986; Weiss,
Clarkson, & Simon, 2002). In the case of manganese
exposure, neurobehavioral and neuropsychiatric symptomology
are apparent long after blood levels and body burden of
manganese have returned to normal (Hochberg et al., 1996;
Huang et al., 1993; 1998). Moreover, neurological and
behavioral changes have been detected in humans exposed to
manganese even in the absence of overt symptoms of
manganese toxicity (Mergler, 1999).
In conclusion, this thesis demonstrates that exposure
to manganese during neonatal development causes both short-
and long-term changes in behavior. Although, this thesis
does not provide data supporting a relationship between
early manganese exposure and ADHD, it does provide evidence
that manganese causes both long-term behavioral changes and
reductions in striatal dopamine transporters.
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